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The understanding and importance of incorporating the microbiome as a measurable 
indicator of toxicity has only recently come about in the scientific discipline of ecotoxicology. 
The microbiome, specifically the gut microbiome, plays a critical role in host homeostasis where 
it can communicate, interact and influence the nervous, immune and gastrointestinal systems as 
well as the brain. The microbiome holds importance in ecotoxicology studies as microbiota can 
detoxify and activate toxicants and, if perturbed by contaminants, influence the host response to 
these compounds. Given some gut florae can influence neurochemicals, synthesize biogenic 
amines and express neurotransmitter:sodium symporters, it is valuable to understand how 
antidepressants, specifically selective serotonin reuptake inhibitors (SSRIs), can affect the gut 
microbiome. SSRIs are known contaminates found in aquatic environments, which has led to an 
abundance of ecotoxicology studies covering behavior, reproduction, and developmental 
research on aquatic organisms. However, no study has yet been identified assessing the gut 
microbial response to SSRIs in the field of ecotoxicology such as within fish. A preliminary 
study was first conducted to identify if fluoxetine, a common SSRI, can impede growth of 
bacterial cells cultured from the gut of fathead minnow (Pimephales promelas). This was an in 
vitro study, where bacterial cells were inoculated with a serial dilution ranging from 0.015 to 128 
µg/mL of fluoxetine. At nominal fluoxetine concentrations of 32, 64 and 128 µg/mL, growth of 
bacterial cells was found to indeed be inhibited. With preliminary results identifying inhibition of 
growth due to fluoxetine exposure, an in vivo study followed where fathead minnows were 
exposed to three concentrations of fluoxetine or a control. Nominal concentrations consisted of 
0.01, 10 and 100 µg/L. After a 28-day exposure to aqueous fluoxetine, fish were euthanized, 
intestines were extracted and DNA extraction, amplification, purification and sequencing was 
conducted on the 16S rRNA gene to identify the abundance and diversity of the gut microbiome. 
Results indicated that the highest exposed group held a significantly altered gut microbiome 
compared to the control, low and middle groups. It was also found that male and female fish hold 
distinct gut microbiomes. These findings are the first to identify that SSRIs can influence the gut 
microbiome of fish, although at a concentration much higher than known environmental 
concentrations. While the results are inconclusive at lower concentrations more commonly 
measured in the aquatic environment, insight still may be gained into how potential mixtures and 




can also help interpret how such concentrations of fluoxetine may influence the gut microbiome 
of other organisms using the cross-species extrapolation hypothesis to predict similar effects on 
evolutionarily conserved molecular targets. Possible next steps would be to perform a mixed-
omics approach to accurately understand not only “who is there” but “what they are doing”; 
essentially, how the gut microbiota is functioning and interacting with its host. These methods 
could provide a more in-depth examination into how perturbations of the gut microbiome may be 





















I would like to thank my graduate supervisor, Dr. John Giesy, for providing me 
tremendous guidance, mentorship and support throughout my degree and to my committee 
members, Dr. Paul Jones and Dr. Markus Hecker, providing me with feedback and assistance on 
my work. I would also like to thank Dr. Joseph Rubin and Michelle Sniatynski from the 
Department of Veterinary Microbiology at the University of Saskatchewan for their immense 
support and use of their lab while running minimum inhibition concentration assays, to Mark 
Lyte from the College of Veterinary Medicine at Iowa State University for his guidance in 
conducting biofilm assays to determine bacterial cell receptors and to Hilary Burgess from the 
Department of Veterinary Pathology at the University of Saskatchewan for her help with 
immune cell identification. I would also like to acknowledge and thank my funding sources, the 
University of Saskatchewan Dean’s Scholarship and the Toxicology Centre Devolved 
Scholarship which have assisted me in the ability to conduct my research.  
I would like to thank the Giesy Lab, notably Drs.Yuwei Xie and Abby DeBofsky for 
helping identify my passion for the microbiome and for their incredible support and assistance 
from conducting my fish exposure, to DNA extraction and sequencing to bioinformatic guidance 
to writing, thank you! Thank you to Anna Kennedy for all her hard work in helping with my fish 
exposure and her organizational skills, and to Dr. Jon Challis for his analytical chemistry skills 
and his mentorship. Thank you to Phil Ankley for his assistance in sequencing and passion for 
bioinformatics and deep thoughts. A big thank you to the toxicology graduate students who have 
been such a supportive and loving community.  
Importantly, I would like to thank my family who has continuously given me support, 
motivation and love during my graduate studies. A big thank you to my sisters, Annika and 
Eliza, for a constant supply of advice and always knowing how to make me laugh and to my 
parents who have inspired me to find my passion and love for the sciences. And to Kate, for her 
unconditional love, enthusiasm, inspiration, and shoulder to lean on. You have helped me 






TABLE OF CONTENTS 
PERMISSION TO USE ................................................................................................................................. i 
ABSTRACT .................................................................................................................................................. ii 
ACKNOWLDEGMENTS ........................................................................................................................... iv 
TABLE OF CONTENTS .............................................................................................................................. v 
LIST OF TABLES ...................................................................................................................................... vii 
LIST OF FIGURES ................................................................................................................................... viii 
LIST OF ABBREVIATIONS ....................................................................................................................... x 
PREFACE ................................................................................................................................................... xii 
CHAPTER 1: GENERAL INTRODUCTION ............................................................................................. 1 
1.1. Introduction ................................................................................................................................... 2 
1.2. The Gut Microbiome ..................................................................................................................... 2 
1.2.1. The microbiome-gut-brain-axis ............................................................................................ 3 
1.2.2. Homologous transporters on bacterial and host cells ............................................................ 5 
1.3. Serotonin and SERT ..................................................................................................................... 5 
1.3.1. Serotonin signaling system ................................................................................................... 6 
1.3.2. Selective serotonin reuptake inhibitors ................................................................................. 7 
1.4. Wastewater effluent and SSRIs ..................................................................................................... 8 
1.4.1. SSRIs and aquatic ecotoxicology .......................................................................................... 8 
1.5. SSRIs and the gut microbiome ...................................................................................................... 9 
1.6. Characterizing the gut microbiome through 16S rRNA sequencing ........................................... 10 
1.7. Rational ....................................................................................................................................... 10 
1.8. Objectives and Hypotheses ......................................................................................................... 11 
CHAPTER 2: MINIMUM INHIBITORY CONCENTRATION ASSAYS FOR THE DETERMINATION 
OF ANTIMICROBIAL PROPERTIES OF FLUOXETINE ON CULTURED BACTERIAL CELLS 
FROM THE GUT OF FATHEAD MINNOW (PIMEPHALES PROMELAS)........................................... 13 
Abstract ................................................................................................................................................... 15 
Introduction ............................................................................................................................................. 16 
2.2. Materials and methods ................................................................................................................ 17 
2.2.1. Experimental design ............................................................................................................ 17 
2.2.2. Fluoxetine quantification .................................................................................................... 18 
2.3. Results ......................................................................................................................................... 19 
2.4. Discussion ................................................................................................................................... 22 
CHAPTER 3: EFFECTS OF AQUEOUS FLUOXETINE ON THE GUT MICROBIOME OF ADULT 




Abstract ................................................................................................................................................... 26 
3.1. Introduction ................................................................................................................................. 28 
3.2. Materials and methods ................................................................................................................ 30 
3.2.1. Fish husbandry, aqueous exposure and dissection .............................................................. 30 
3.2.2. Quantification of aqueous fluoxetine .................................................................................. 31 
3.2.3. Extraction of Bacterial DNA and 16S rRNA metagenomics .............................................. 31 
3.2.4. 16S rRNA metabarcoding and bioinformatics .................................................................... 32 
3.3. Statistics ...................................................................................................................................... 32 
3.4. Results ......................................................................................................................................... 33 
3.4.1. Aqueous concentration of fluoxetine and fitness of Fish .................................................... 33 
3.4.2. Host sex shaped gut microbiome ........................................................................................ 34 
 ............................................................................................................................................................ 37 
3.4.3. Female gut microbiome response to fluoxetine exposure ................................................... 38 
3.4.4. Male gut microbiome response to fluoxetine exposure ...................................................... 39 
3.5. Discussion ................................................................................................................................... 41 
3.6. Conclusions ................................................................................................................................. 45 
CHAPTER 4: GENERAL DISCUSSION .................................................................................................. 46 
4.1. Project focus and objectives ........................................................................................................ 47 
4.2. Summary of findings ................................................................................................................... 47 
4.2.1. Minimum inhibitory concentrations .................................................................................... 47 
4.2.2. Analyzing sex differences and the effects of fluoxetine on the gut microbiome of fathead 
minnow 48 
4.2.3. Linking MIC and metabarcoding results ............................................................................. 50 
4.3. Limitations of research and recommendations for future work .................................................. 51 
4.3.1. Development limitations to identify transporters on bacterial cells .................................... 51 
4.3.2. The pros and cons of 16S rRNA metabarcoding ................................................................ 51 
4.3.3. Future work incorporating omics techniques for functional analyses ................................. 52 
4.4. Concluding statements ................................................................................................................ 53 
APPENDICES ............................................................................................................................................ 55 






LIST OF TABLES 
 
Table 2.1| Nominal and measured concentrations of fluoxetine in agar used for MIC assays. The greater 
the nominal concentration the less percent error was observed. ........................................................... 19 
 
Table 2.2| MIC results depicting measured fluoxetine concentrations where inhibition of bacterial growth 
occurred. Asterisks represent the five strains cultured from the gut microbiome of fathead minnows. NI 
represents “No Inhibition” of growth. Because true concentrations were not measured for the nominal 128 
µg/mL fluoxetine-agar mixture, ~128 is shown here. Wild Bird E. coli 136C and 112A were found to be 
inhibited at 128 µg/mL in replicate 1 but not replicate 2 plates. ........................................................... 20 
 
Table 3.1| Mean and standard deviation (SD) of aqueous concentrations of fluoxetine right after each 
water-change (1st sampling), 24 hours after renewals (2nd sampling) and predicted plasma concentration 
based on the fish plasma model and linear equation model identified by Margiotta-Casaluci et al. (2014).
....................................................................................................................................................... 34 
 
Appendix B| Boxplots comparing condition factor against exposure concentrations (A) female fish 
(ANOVA test, p>0.05; n=45); (B) male fish (ANOVA test, p<0.05; n=32). No significant differences 
were identified between concentration of fluoxetine and condition factor of male and female fish. 
(Chapter 3). ..................................................................................................................................... 57 
 
Appendix F| Table showing reads per sample before and after filtering, denoising, merging and removing 
of chimeras. (Chapter 3) ................................................................................................................... 61 
 
Appendix L| Summary of statistics from the Neighborhood Selection Network analyzer for male and 












LIST OF FIGURES 
 
Image 2.1| Images of fluoxetine inoculated petri-dishes and bacteria growth. (A) depicts duplicates of 32 
µg/L of fluoxetine dishes next to the control, (B) 64 µg/L fluoxetine dishes and control, and (C) shows the 
128 µg/L fluoxetine dishes and control. Controls are shown on the right side in photographs A and C and 
on the left side in photograph B. ....................................................................................................... 21 
 
Illustration 3.1| Graphical abstract representing the gut microbial composition of fathead minnows when 
exposed to fluoxetine. ...................................................................................................................... 27 
 
Figure 3.1| Alpha diversity matrices comparing female (n = 42) and male (n = 31) fish: (A) Faith 
Phylogenetic Diversity; p = 6.127e-06 and (B) Shannon Diversity Index; p = 0.02. (C) Unweighted 
UniFrac and (D) Weighted UniFrac depicting the distances in microbial composition between female and 
male fish; Unweighted PERMANOVA; F = 11.96, p = 0.001, Weighted PERMANOVA; F = 4.25, p = 
0.006. (E) Cladogram of taxonomic levels from a LEfSe analysis. Taxa in red are differentially and 
greater expressed in female fish and those in green are greater expressed in males. (F) Boxplot depicting 
relative abundant families found to be differentially expressed in females versus males. Significant 
correlations: *, p < 0.05; **, p < 0.01; ***, p < 0.001. F, female; M, male. .......................................... 36 
 
Figure 3.2| Neighborhood Selection Network analyses indicating an increase of fluoxetine to be 
significantly correlated to major clusters of class level taxa. Clusters from (A) female fish contain more 
nodes and thus higher alpha diversity. Clusters from (B) male fish hold less nodes representing less 
abundance of class level taxa. Red lines indicate a negative correlation between fluoxetine and abundance 
of classes while dark blue lines indicate a positive correlation. Light blue lines represent an interaction 
between nodes. Shapes of nodes indicate phylum level while color indicates the node’s class. .............. 37 
 
Figure 3.2| Alpha diversity matrices: Faith Phylogenetic Diversity for (A) females and (F) males, and 
Shannon Diversity Index for (B) females and (G) males. Beta diversity matrices: weighted UniFrac for 
(C) females and (H) males. Unweighted UniFrac distance matrices for (D) females and (L) males. 
Heatmaps (E, Females & J, males) depicting the correlation between proportion of families and the 
fluoxetine concentration fish were exposed to. Abundance of family level taxa are illustrated by the 
greyscale where black indicates higher abundance and white indicates lower abundance. Fish are sorted 
into their fluoxetine concentration groups which can be found vertically (ctrl, low, mid, high). A 
Pearson’s correlation coefficient representing the association between fluoxetine exposure concentration 
and the proportion of families present can be found on the red-blue scale where red relates to a positive 
correlation and blue to a negative correlation between the two variables. Heatmaps for genus and ASV 
levels can be found in Appendices J and K. Significant level: * < 0.05, ** < 0.01, *** < 0.001. ............ 41 
 





Appendix D| NMDS plot based on bootstrap averaged beta-diversities to show the variance of each group 
(chapter 3). ...................................................................................................................................... 59 
 
Appendix G| (A) Top 10 most abundant families in female fish that were significantly reduced in the 
high exposure group compared to controls. (B) Relative abundance of family level taxa that were 
significantly more abundant in the high exposure group compared to controls in females. (Chapter 3) ... 63 
 
Appendix H| Relative abundance of family level taxa that are significantly reduced in the high exposure 
group compared to the control in males (A). Relative abundance of family level taxa that is significantly 
more abundant in the high exposure group compared to controls in males (Chapter 3). ......................... 64 
 
Appendix I| Relative abundances of top 10 Phylum level taxa in (A) females and (B) males. ............... 65 
 
Appendix J| Genera level heatmaps, of females (A) and males (B), representing the correlation between 
abundance of genera level taxa and fluoxetine concentrations. Greyscale indicates proportion of taxa, the 
darker the more abundant. Concentrations of fluoxetine include ctrl, low, mid and high. Pearson’s 
correlation coefficient depicted in the blue-red scale, positive correlation (higher fluoxetine concentration 
and higher abundance of taxa) is shown in red while a negative correlation (high fluoxetine and lower 
abundance of ASVs) is shown in blue. (Chapter 3) ............................................................................ 66 
 
Appendix K| Heatmap of ASVs, Females (A), Males (B), representing the correlation between 
abundance of ASVs and fluoxetine concentrations. Greyscale indicates proportion of taxa, the darker the 
more abundant. Concentrations of fluoxetine include ctrl, low, mid and high. Pearson’s correlation 
coefficient depicted in the blue-red scale, positive correlation (higher fluoxetine concentration and higher 
abundance of ASVs) is shown in red while a negative correlation (high fluoxetine and lower abundance of 
ASVs) is shown in blue. ................................................................................................................... 67 
 
Appendix M.1| Assessment of log-transformed average white blood cell counts with fluoxetine exposure 
groups. The middle exposure group was found to have a higher white blood cell count than controls (A). 
Log transformed white blood cell counts in relation to sex of fish (B). Separation of sexes within each 










LIST OF ABBREVIATIONS 
 
5HIAA  5-hydroxyindoleacetic acid  
5-HT   5-hydroxytryptamine or serotonin 
ANOVA  Analysis of variance 
ASV   Amplicon sequence variants 
ATCC   American Type Culture Collection 
CNS   Central nervous system   
DAT   Dopamine transporter 
EC   Enterochromaffin  
ENS   Enteric nervous system 
GABA   Gamma-aminobutyric acid 
HPA   Hypothalamic-pituitary-adrenal 
HPG   Hypothalamic-pituitary-gonadal 
HPI   Hypothalamic-pituitary-interrenal 
HPLC   High-performance liquid-chromatography  
HT1A   Serotonin 1A receptor 
HT2A   Serotonin 2A receptor 
HTPC   Human therapeutic plasma concentration range 
LCMS   Liquid chromatography mass spectrometry  
LDA   Linear discriminant analysis 
LEfSE   Linear discriminant analysis effect size  
log Koc   Organic carbon normalized sorption coefficient  
Log Kow  Octanol-water partition coefficient 
LeuT   Leucine transporters 
MAO-A  Monoamine oxidate type A 
MAOI   Monoamine oxidase inhibitors 




MS-222  Tricaine methanesulfonate 
NET   Norepinephrine transporter 
NGS   Next generation sequencing 
OCD   Obsessive compulsive disorders 
OECD   Organization for Economic Co-operation and Development 
PCR   Polymerase chain reaction 
PERMANOVA Permutational multivariate analysis of variance  
PERMDISP  Homogeneity of multivariate dispersion    
SCFA   Short chain fatty acid 
SERT   Serotonin reuptake transporter 
SPE   Solid phase extraction 
SSRI   Selective serotonin reuptake inhibitor 
TCA   Tricyclic antidepressants 



















This thesis was prepared in a manuscript style format following the University of Saskatchewan 
College of Graduate Studies and Research guidelines. Accordingly, chapter 1 of this thesis is a 
general introduction to the work conducted while chapters 2 and 3 have been prepared for a peer-
reviewed scientific journals, and chapter 4 is general discussion pertaining to the above chapters. 
Therefore, there may be some overlap and redundancy of background information. All references 
are cited at the end of the thesis while supporting information for the above chapters are within 
the appendix. The appendix also provides an informative assessment conducted during my 






























1.1. Introduction  
The complex microbial network that dominates Earth plays a vital role in the homeostasis of 
all organisms and their ecosystems. These networks are the building blocks of life on our planet, 
supporting soil decomposition and nutrient uptake in plants and the ability for organisms to 
develop, metabolize, and support other physiological and cellular processes (Layeghifard et al., 
2017; Tinker, 1984; Van Veen and Kuikman, 1990). Studies involving understanding of how 
these microbial communities work, specifically understanding endogenous microbes (i.e., the gut 
microbiome) living within other organisms, have proliferated within the last decade (Goodrich et 
al., 2014). In regard to the work described here, there continues to be a need to clarify the role of 
the microbiome in ecotoxicological research, to understand not only how the microbiome is 
impacted by xenobiotic exposure, but also how a shift in the microbial makeup of such a vital 
community due to a toxicant can affect host health (Adamovsky et al., 2018). 
1.2. The Gut Microbiome 
A network of microorganisms coexisting endogenously within a host organism is known as a 
microbiome (Sekirov et al., 2010). In humans, microbes can be found colonizing all surfaces of 
the body including the skin and mouth, yet 70% of these microorganisms are located within the 
gastrointestinal (GI) tract and colon (Rooks and Garrett, 2016; Sekirov et al., 2010). The makeup 
of the gut microbiome is complex, consisting mainly of bacteria as well as archaea, viruses, fungi 
and protozoans (Jandhyala et al., 2015; Sekirov et al., 2010). The composition can vary between 
organisms and among the same species. At times, the composition can fluctuate within an 
individual as well, yet a set of core microbes have been identified that are markedly consistent 
within similar species (Rooks and Garrett, 2016).  
Sex is an important variable in terms of the gut microbiome composition (Kim et al., 2020). 
Mammalian, as well as fish studies have recently been conducted determining the distinction of 
the gut microbiome between the two sexes (DeBofsky et al., 2020; Lozano et al., 2018; Stoffel et 
al., 2020), realizing that host hormones are key to composition of the microbiome (Chen and 
Madak-Erdogan, 2016; Markle et al., 2013; Org et al., 2016; Yurkovetskiy et al., 2013). Many 
studies conducted revealed that females host a more abundant microbiome where alpha diversity 




Yurkovetskiy et al., 2013). During puberty, the microbiome has been shown to become less 
abundant in males (Yurkovetskiy et al., 2013). The potential mechanism for this is that androgen 
receptor activity may influence composition of the microbiome in males (Markle et al., 2013). 
Some gut microbiota also have the ability to metabolize hormones and influence the expression 
of host genes relating to sex hormone function (Kunc et al., 2016). There is still a need to 
investigate why the microbiota composition differs between sexes and the function and 
connection between hormones and the microbiome. However, with this emerging evidence, it is 
critical to acknowledge sex within microbiome studies, for sex-specific differences may occur 
(Kim et al., 2020). 
Only recently has it come to light that the community of microbes living within an organism 
should be considered a functioning organ within the body (Possemiers et al., 2011). This tightly 
intertwined network can support several essential systems within the body including the immune 
and nervous systems, and the breakdown, metabolism and synthesis of key nutrients, such as 
short-chain fatty acids (SCFA) and biogenic amines such as dopamine and serotonin (Lyte and 
Brown, 2018; Pessione and Cirrincione, 2016; Rhee et al., 2009; Turnbaugh et al., 2007). These 
microbes not only support their host, the organism they live within, but a symbiotic, bidirectional 
relationship forms, allowing for cross-talk between host and microbiome. If dysbiosis, or an 
imbalance of commensal microbiota occur, host homeostasis can be impacted resulting in 
susceptibility to allergens as well as metabolic and inflammatory conditions (Rooks and Garrett, 
2016). 
1.2.1. The microbiome-gut-brain-axis 
The enteric nervous system holding more than 500 million neurons can be found 
embedded in the gastrointestinal lining (Furness, 2006). This system along with the central 
nervous system, autonomic nervous system, the hypothalamic-pituitary-adrenal (HPA) axis and 
the brain and spinal cord, create a bidirectional network that allows crosstalk between the gut and 
brain (Carabotti et al., 2015). Activation of these systems through cytokines, hormones, an 
amalgam of specialty cells and afferent and efferent signaling, allows for communication 
between the gut and brain (Butler et al., 2019; Carabotti et al., 2015). It has been shown that 
microbiota can also influence the interaction between the brain and gut (Emeran A Mayer et al., 




microbiome can influence and communicate with its host has proliferated (Butler et al., 2019). 
The microbiome is highly influential in terms of stress responses, immunity and the production 
of  SCFA and neurotransmitters (Butler et al., 2019; Macpherson and Harris, 2004; Rooks and 
Garrett, 2016; Sekirov et al., 2010). Evidence of these abilities come from gnotobiotic (lacking 
microflora) animals, exhibiting altered responses to stressors due to the lack of bacteria 
metabolizing vital molecules essential for the development of the enteric nervous system and the 
HPA axis (Rooks and Garrett, 2016). Noticeable differences in the release of certain molecules 
or hormones have been identified during stress responses including higher adrenocorticotropic 
hormone and corticosterone release during a stress response in gnotobiotic mice (Sudo et al., 
2004), as well as a significant reduction in serotonin (Wikoff et al., 2009), specifically during a 
stressful event (Lyte et al., 2020). These studies shed light on the inability for a more controlled 
response to stressors when there is a lack of microbiota. 
 Regarding immunomodulatory effects, gnotobiotic animals again give us insight into the 
importance of the microbiome on the immune system. Macpherson and Harris (2004) 
demonstrated that in mice lacking commensal microbiota, the immune system is underdeveloped 
where numbers of several different types of immune cells including CD4+ T cells and IgA-
producing plasma cells are reduced and the spleen and lymph nodes, where the majority of all 
immune-cells is made, are lacking structure. Interestingly, such malformations are quickly 
reversed when these gnotobiotic animals are grouped with others containing microflorae 
(Macpherson and Harris, 2004). During the development of the immune system, bacteria are 
critical in the activation of certain receptors eventually causing cytokine production (Butler et al., 
2019; Chung et al., 2012).  
 One of the largest roles microbiota play in the body is the production of SCFAs, which 
are responsible for a multitude of functions including acting as a source of energy for epithelial 
cells in the intestine and influencing many molecules that in turn act on metabolism, the immune 
system, liver and the brain (Butler et al., 2019). Butyrate, a SCFA produced specifically by 
bacteria, holds a large impact on gene transcription which can eventually influence epigenetic 
processes (Butler et al., 2019). Studies have attributed butyrate with antidepressant like effects 




models (Ferrante et al., 2003; Govindarajan et al., 2011; Schroeder et al., 2007; Sharma et al., 
2015).  
 Many microbes are also capable of producing neurotransmitters such as gamma-
aminobutyric acid (GABA), acetylcholine, dopamine and serotonin. The production of these 
biogenic amines in microbes are termed “biomediators” rather than neurotransmitters, for their 
role in microorganisms pertain to intercellular communication, growth and colonization 
(Roshchina, 2010). Importantly, the production of these molecules by microbiota allows for 
cross talk between bacteria and host giving insight into how microbes can directly interact with 
host cells leading to the influence of anxiety, depression, cognition and mood (Butler et al., 
2019).  
1.2.2. Homologous transporters on bacterial and host cells 
Not only have bacteria been found to produce neurotransmitters, but several express 
homologous transporter proteins to those of host norepinephrine, dopamine and serotonin 
transporters (NET, DAT and SERT, respectively) (Androutsellis-Theotokis et al., 2003). These 
transporters, including the ones found on bacterial cells, are all within the same 
neurotransmitter:sodium symporter family (Zhou et al., 2009). The bacterial transporters have 
been mainly identified as amino-acid transporters such as tryptophan transporters from E. coli 
(Androutsellis-Theotokis et al., 2003) and leucine transporters (LeuT) from Aquifex aeolicus 
(Yamashita et al., 2005). Importantly, LeuT has been studied to better understand antidepressant 
drug abilities to block neurotransmitter reuptake (Zhou et al., 2007). These understandings have 
helped to identify how antidepressants, such as selective serotonin reuptake inhibitors (SSRIs) 
bind to SERT, and have fueled the question of whether these pharmaceuticals have the capacity 
to interact with commensal microbiota and so potentially alter the microbiome (Lyte et al., 
2019). 
1.3. Serotonin and SERT 
Although most notably thought of as a neurotransmitter modulating mood and brain function, 
95% of serotonin is produced in the gut (Gershon and Tack, 2007). Serotonin plays an important 




and is critical in the function of the gastrointestinal, cardiovascular, pulmonary and endocrine 
systems (Berger et al., 2009; Gershon and Tack, 2007).  
1.3.1. Serotonin signaling system 
Serotonin or 5-hydroxytryptamine (5-HT) is a monoamine transmitter which can 
influence neurons in the brain and peripheral nervous system. With its modulatory abilities, 
when 5-HT binds to one of its 15 known receptors, it can influence a variety of behavioral 
responses (Berger et al., 2009). The metabolic precursor to serotonin is the essential amino acid, 
tryptophan, found in dietary protein sources such a meat, seeds, dairy and fruit (Jenkins et al., 
2016). While most serotonin is produced within enterochromaffin (EC) cells or neurons within 
the gut, a small portion is produced in the central nervous system (CNS) (Gershon and Tack, 
2007; Jenkins et al., 2016). Tryptophan, once in the CNS, is hydroxylated into 5-
hydroxytrypotphan and then decarboxylated to 5-hydoxytryptamine, or serotonin (Jenkins et al., 
2016). EC cells, being the predominate source of serotonin production within the body, are the 
main source of blood serotonin for blood platelets that are not capable of producing their own 
serotonin (Gershon and Tack, 2007). Within the connective tissue of the lamina propria in the GI 
tract, serotonin is released where it can then act on serotonin receptors. Once serotonin acts upon 
its receptors within the CNS, the enteric nervous system (ENS), or on epithelial or immune cells, 
it is then taken up by SERT, which is found on neurons within the serotonergic nerve terminals 
of the brain, in the enteric nervous system, epithelial cells and on blood platelets. SERT either 
transports 5-HT back into vesicles or the 5-HT is catabolized by monoamine oxidase type A 
(MAO-A) into its metabolite; 5-hydroxyindoleacetic acid (5HIAA) (Coates et al., 2017; Gershon 
and Tack, 2007; Jenkins et al., 2016; Linden et al., 2009; Read and Gwee, 1994). Once in its 
metabolic form (5HIAA), it is then excreted via urine (Read and Gwee, 1994). 
The binding of serotonin to different receptors can cause a variety of modulatory effects. 
For example, depending on which receptor serotonin binds to within the CNS, it can stimulate 
sleep, mood, memory or appetite (Berger et al., 2009; Jenkins et al., 2016). Within the GI tract, 
binding of serotonin to specific receptors can regulate gastric emptying or intestinal peristalsis 
(Grider, 2003; Raybould et al., 2003). Irritable bowel syndrome has also been shown to be 
influenced by serotonin (Coates et al., 2017). For example, the binding of serotonin to 5-HT2A 




HT3 receptors can modulate visceral pain transmission (Coates et al., 2017). Serotonin has been 
found to modulate behaviors similarly within vertebrates including fish, yet for fish, serotonin 
can also influence gas exchange within gills and intestinal osmoregulation (Kreke and Dietrich, 
2008; Morando et al., 2009).  
1.3.2. Selective serotonin reuptake inhibitors 
The role of serotonin in the modulation of almost all functions within the body attests to its 
importance in organism health and function. However, within humans, imbalances of behaviors 
such as depression, anxiety and obsessive compulsive disorders (OCD) have led to the study of 
monoamine oxidase inhibitors (MAOIs), tricyclic antidepressants (TCAs) and eventually SSRIs 
(Ferguson, 2001). SSRIs demonstrate a selective affinity for serotonin reuptake transporter sites 
and thus block serotonin from being taken back up into the neuronal vesicles, allowing for 
prolonged serotonin signaling within the body (Hiemke and Härtter, 2000; Linden et al., 2009). 
SSRIs have been widely used for treatment of several mood and behavior disfunctions and have 
been found to be much safer, with milder side effects than MAOIs and TCAs due to target 
selectivity, solely binding to serotonin receptors (Ferguson, 2001; Hiemke and Härtter, 2000). 
Fluoxetine, trademarked as Prozac®, was the first SSRI introduced to the United States in 1988 
and is currently one of the most widely prescribed SSRIs (Altamura et al., 1994; Ferguson, 2001; 
Luo et al., 2020).  
When orally ingested, the majority of fluoxetine is absorbed and is metabolized into its 
bioactive primary metabolite, norfluoxetine (Hiemke and Härtter, 2000; Kosjek and Heath, 2010; 
Silva et al., 2012; Vaswani et al., 2003). Differing from other SSRI metabolites, norfluoxetine 
retains just as much potency as its parent compound (Kosjek and Heath, 2010). Norfluoxetine is 
then able to inhibit SERT before it undergoes phase 2 hepatic metabolism, where it is converted 
into a more hydrophilic compound in order for it to be excreted in urine (Silva et al., 2012a; 
Vaswani et al., 2003). Norfluoxetine demonstrates a half-life of one to four days and takes on 
average, in a normal pharmacological regime, four weeks to reach steady state levels within the 
human body (Altamura et al., 1994; Vaswani et al., 2003). Nonlinear pharmacokinetics have 
been reported for fluoxetine where at higher doses the plasma concentration is disproportionately 
higher (Altamura et al., 1994). The majority of fluoxetine, 60 to 75%, is excreted through the 




1.4. Wastewater effluent and SSRIs 
With exponential growth in the use of SSRIs worldwide, they are now ubiquitous and 
commonly detected within aquatic environments (Silva et al., 2015). SSRIs enter wastewater 
treatment plants (WWTPs) either through domestic waste (i.e., flushing expired/unused pills or 
human excretion) or from municipal waste from healthcare facilities (Schultz et al., 2011; Silva 
et al., 2015). Fluoxetine, among the most prevalent SSRIs found downstream of WWTPs, has 
been detected in waterbodies at ng/L to µg/L (Brooks et al., 2003a; Kolpin et al., 2002; Metcalfe 
et al., 2010; Silva et al., 2012). Fluoxetine demonstrates an octanol-water partitioning coefficient 
(log Kow) between 1.22 to 4.0 indicating its relatively low water solubility. It can demonstrate a 
half-life of around 3 days in water and can adsorb to particulates, soils and sediments with a log 
Koc (organic carbon normalized sorption coefficient) of 3.82 to 5.63 (Black and Armbrust, 2007; 
Gaworecki and Klaine, 2008; Silva et al., 2015; Velázquez and Nacheva, 2017). Degradation of 
fluoxetine in water is slow where it does not readily biodegrade by wastewater treatment, it is 
resistant to photolytic breakdown, and it quickly absorbs to sediments within rivers and streams 
allowing it to last longer within aquatic habitats (Black and Armbrust, 2007). 
1.4.1. SSRIs and aquatic ecotoxicology 
Serotonin is an evolutionarily conserved molecule found in all vertebrates (McDonald, 
2017). For instance, all but one of the serotonin receptors identified in mammals have been 
found in fish and the binding of SSRIs occurs on the serotonin transporter, SERT, in fish, similar 
to that of mammalian transporter binding (McDonald, 2017). A few differences in the teleost fish 
serotonin system compared to mammalian include the fact that serotonin can freely pass though 
the fish blood brain barrier (BBB) allowing for peripheral serotonin to influence the brain, and 
instead of enterochromaffin cells that produce the majority of 5-HT in humans, fish have enteric 
neurons along the intestinal walls that are the main source of this molecule (Anderson et al., 
1988; Caamaño-Tubío et al., 2007; Khan and Deschaux, 1997; Velarde et al., 2010). There is 
still a continued need to study the serotonin system in fish, however, from previous work, 
serotonin has been identified as a vital part of fish homeostasis (reviewed by McDonald (2017)). 
Numerous ecotoxicology studies have been conducted examining the effects of SSRIs on 




et al., 2015). The results from such studies demonstrate reductions in aggression and anxiety 
(Ansai et al., 2016; Barbosa et al., 2012; Loveland et al., 2014) potentially through the 
stimulation of the 5-HT1A receptor which can lead to a reduced predator-prey responses 
(McDonald, 2017), appetite suppression (Mennigen et al., 2010) where serotonin is known to 
inhibit food intake responses by decreasing brain glycogen (McDonald, 2017; Pérez Maceira et 
al., 2014), and the stimulation of the hypothalamic-pituitary-inter-renal (HPI) and hypothalamic-
pituitary-gonadal (HPG) axes leading to modulatory effects on reproductive behavior (Martin et 
al., 2017; McDonald, 2017).  Although such reproductive effects demonstrate some incongruities 
as reviewed by McDonald (2017). With continued research regarding the effects of SSRIs on 
fish health, there still are several gaps to be filled where serotonin is known to play important 
roles including in the GI and cardiovascular systems (McDonald, 2017).  
1.5. SSRIs and the gut microbiome 
While there is an understanding of the influential role of the gut microbiome on several 
systems throughout the body including the regulation of serotonin (Fung et al., 2019) and 
homologous sodium symporters on bacterial and host cells, no studies have been conducted to 
assess the influence of SSRIs on the gut microbiome of aquatic organisms. In recent years, some 
studies have  identified shifts in the microbial makeup of rodent and human microbiomes due to 
ingestion of SSRIs as well as studying the antimicrobial properties of SSRIs on commensal 
bacteria (Ait Chait et al., 2020; Cussotto et al., 2018; Fung et al., 2019; Lyte et al., 2019; Lyte 
and Brown, 2018; Sun et al., 2019; Zhang et al., 2021). Results include inhibition of growth, in 
vitro, of several dominate commensal microbiota in the human gut (Ait Chait et al., 2020; 
Cussotto et al., 2018) where some may hold biogenic amine transporters that are known to be 
inhibited by SSRIs (Fung et al., 2019; Lyte and Brown, 2018). Studies have also found that 
fluoxetine can induce changes in community structure and diversity of the microbiome of 
rodents (Fung et al., 2019; Sun et al., 2019) and the susceptibility of microbes associated with a 
healthy status to antidepressants (Maier et al., 2018).  With these recent observations, the 
importance of the microbiome on host homeostasis, homologous biogenic amine transporters 
found both on bacterial and eukaryotic cells and recent understandings of the importance of the 
microbiome in aquatic toxicological studies, it is desirable to better understand the 




1.6. Characterizing the gut microbiome through 16S rRNA sequencing  
Most commensal bacteria residing within the gut of living organisms are unculturable 
(Stewart, 2012). Because these microbiota need a very specific environment to survive, and are 
sensitive to ambient oxygen, it is impractical to use culturing methods to identify the microbial 
communities that make up the gut microbiome (Browne et al., 2016). Thus, the development and 
use of next-generation sequencing (NGS) technologies have become important in the discovery 
of the abundance and diversity of the gut microbiome (Duperron et al., 2020; Walker et al., 
2014). Within NGS there are several approaches to advance our knowledge on not only the 
identification of microbes present using metataxonomics and metagenomics techniques, but how 
these microbes function and interact with their host through the use of metatranscriptomics, 
metaproteomics and metabolomics (Whon et al., 2021). For this work, metataxonomic 
sequencing was conducted to better characterize the gut microbiome of fathead minnow 
(Pimephales promelas) after exposure to fluoxetine. Metataxonomics is a targeted approach 
unlike metagenomics. It relies on targeting a specific gene region of the 16S rRNA gene found in 
almost all bacteria as well as some archaeal taxa (Hilton et al., 2016; Walker et al., 2014; Whon 
et al., 2021). This technique is the most widely used approach in understanding the abundance 
and types of microbes present in microbiome studies (Hilton et al., 2016). Using the 16S rRNA 
sequencing technique, the taxonomic classification, structure and composition of the microbiome 
can be identified (Whon et al., 2021). After DNA extraction, a specific hypervariable region of 
the 16S rRNA gene is amplified using polymerase chain reaction (PCR) where an amplicon 
library is created. Once PCR products are purified, the amplicons are ready for sequencing 
(Kumar et al., 2014). After sequencing of the hypervariable region of the 16S rRNA gene, 
bioinformatics is performed to cluster sequence reads into amplicon sequence variants (ASVs) 
based on 97% identity of the reads. Once clustered, phylogenetic relationships, relative 
abundance and diversity analysis can then be conducted (Kuczynski et al., 2011; Kumar et al., 
2014). 
1.7. Rational  
Gut microbiota hold critical roles in the homeostasis of their host organism. Only recently 
have studies emerged within ecotoxicology to better understand the influential capabilities these 




understanding of the microbiome-gut-brain axis, homologous serotonin transporters on microbial 
cells, and the antibiotic-like effects antidepressants have on commensal bacteria in vitro, give 
way to the importance of understanding how SSRIs affect the gut microbiome. Due to continued 
release of pharmaceuticals such as SSRIs into aquatic environments, it is critical to not only look 
at physiological, behavioral, and molecular responses of organisms to these contaminants, but 
also to understand how the commensal bacteria, tied to almost all functions of their host, are 
impacted.  
1.8. Objectives and Hypotheses 
The objectives of this study included:  
1) Identify if fluoxetine holds antimicrobial properties on bacterial cells, cultured from the 
gut microbiome of fathead minnows, a commonly studied fish used in ecotoxicological 
studies. 
Ho1: In vitro, no antimicrobial effects will be found on bacteria cells cultured 
from the gut microbiome of fathead minnows.  
 
2) Characterize the differences in the gut microbiome of female and male fathead minnows, 
using 16S rRNA metabarcoding techniques.   
Ho2: No differences in gut microbial makeup will be identified between male and 
female fish. 
 
3) Identify potential dysbiosis in the gut microbiome of fathead minnows when exposed to 
select concentrations of fluoxetine during a 28-day period using 16S rRNA 
metabarcoding. 
Ho3: No alterations in abundance or distribution of the gut microbiome will be 
identified after fathead minnows are exposed to any concentration of fluoxetine 
for 28 days. 
 




Ho4: No sex-specific responses of the gut microbiome will be identified after 






















CHAPTER 2: MINIMUM INHIBITORY CONCENTRATION ASSAYS FOR THE 
DETERMINATION OF ANTIMICROBIAL PROPERTIES OF FLUOXETINE ON 




The main objective of Chapter 2 was to run a preliminary study to determine if fluoxetine holds 
antimicrobial properties on bacterial cells extracted from the gut of fathead minnows in-vitro. 
The data generated from these assays gave validity to continue running an in-vivo study to 
determine the effects of fluoxetine on the gut microbiome of exposed fathead minnows (Chapter 
3). Chapter 2 has been prepared in a manuscript style and is intended to be submitted to the peer-
reviewed journal Scientific Reports. 
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Toxicants can impact the microbiome of the gut and further influence host health. To better 
assess if a contaminant holds antimicrobial properties, an in vitro assay may be performed on 
cultured bacterial cells. A minimum inhibitory concentration assay was run to determine if the 
compound, fluoxetine, a common selective serotonin reuptake inhibitor found in aquatic 
environments, may impede growth of bacteria cultured from the gut microbiome of fathead 
minnow (Pimephales promelas). Bacterial cells were exposed to serial dilutions of fluoxetine 
ranging from 0.015 to 128 µg/mL. After overnight incubation, colonies were counted to 
determine growth of bacteria. At 32, 64 and 128 µg/mL, growth of select fathead minnow 
bacteria were found to be inhibited. This preliminary data can be used as an indicator that 
fluoxetine holds some antimicrobial properties and could potentially affect gut microbiota 

















The cross-talk between the enteric nervous system, the immune system and the gut 
microbiome, and the gut microbiome’s ability to regulate several physiological functions within 
its host, gives way to the importance of gut microbiota on overall homeostasis of host organisms 
and continues to be expounded upon (Carabotti et al., 2015; Cryan and O’Mahony, 2011; 
Evariste et al., 2019; Rooks and Garrett, 2016). With our knowledge of a microbiome-gut-brain 
axis and our understanding of the biotransformation abilities of these microbes, it is deemed 
useful to understand how contaminants, such as antidepressants found in wastewater effluent, 
may bidirectionally influence the symbiotic relationship between the gut microbial communities 
and the host organism (Adamovsky et al., 2018; Evariste et al., 2019).  
Selective serotonin reuptake inhibitors (SSRI) are common types of antidepressants that bind 
to serotonin reuptake transporters (SERT) on neurons extending the availability of serotonin 
within the synaptic space (Altamura et al., 1994). SERT is a member of the 
neurotransmitter:sodium symporter (NSS) family along with the norepinephrine and dopamine 
transporters (NET and DAT) (Androutsellis-Theotokis et al., 2003; Zhou et al., 2009). 
Interestingly, some bacteria also express homologous proteins found in this same family which 
are used mainly as amino acid transporters (Zhou et al., 2009). One example is the leucine 
transporter (LeuT) found on Aquifex aeolicus. In fact, LeuT has been used to better understand 
the dynamics behind how SSRIs may bind to neurotransmitter symporters (Yamashita et al., 
2005; Zhou et al., 2009). One of the most widely prescribed SSRIs, fluoxetine (Altamura et al., 
1994), has been shown to bind to LeuT, inhibiting its transport ability (Zhou et al., 2009). In 
recent findings, the antimicrobial properties of SSRIs have been determined for several other 
bacterial species, most likely due to binding affinity of homologous transporters (Bohnert et al., 
2011; Lyte and Brown, 2018; Munoz-Bellido et al., 2000). Due to bacterial inhibitory properties 
of SSRIs, it is important to determine whether these antidepressants can exert an effect on the gut 
bacteria of a host that willingly consumes SSRIs and on organisms that may be involuntarily 
exposed to them due to polluted waters and habitats.  
SSRIs have been detected downstream of wastewater treatment plants and in surface waters 
(Kolpin et al., 2002; Metcalfe et al., 2010; Silva et al., 2012). A multitude of studies have been 




(Brooks et al., 2003b; Foran et al., 2004; Lister et al., 2009; McDonald, 2017; Painter et al., 
2009; Polverino et al., 2021). However, no study has yet been conducted to better understand if 
fluoxetine can indeed perturb bacteria living commensally in the gut of aquatic organisms and 
how this may affect the long-term homeostasis of the host.  
To better understand if fluoxetine can impact gut microbiota of a commonly studied fish 
species, fathead minnow (Pimephales promelas), an in vitro bacterial cell study was first 
conducted. Minimum inhibitory concentration (MIC) assays were performed to identify if 
fluoxetine can impede bacterial growth. Five dominant bacterial species cultured from the gut 
microbiome of fathead minnows as well as several bacterial cells used in conventional MIC 
testing, were exposed to serial dilutions of fluoxetine ranging from 0.015 µg/mL to 128 µg/mL. 
After overnight incubation, colonies were counted to identify growth at each concentration.  
2.2. Materials and methods 
2.2.1. Experimental design 
Minimum inhibitory concentration (MIC) assays were performed to identify whether 
fluoxetine can inhibit growth of several strains of bacteria, including those cultured from the gut 
of fathead minnows. The MIC method is defined as being the lowest concentration of the 
presumed antimicrobial agent that inhibits visible growth of the bacteria or microorganisms 
within a specific time-frame (EUCAST and ESCMID, 2003). Bacteria were cultured from the 
gut of fathead minnows by removing fish intestines, which were then homogenized and plated at 
serial dilutions of 10-6, 10-5, 10-4 using three different medias including blood, nutrient, and 
MacConkey. Plates were incubated at 37ºC until growth occurred. Growths were differentiated 
then plated separately and incubated again. Once culture isolation was achieved, bacteria were 
sent for sequencing using the cpn60 primers (Fernando and Hill, 2021). When bacteria were 
identified and sequenced they was stored at -80 ºC until further use. Cultured bacteria consisted 
of Aeromonas veronii AMC 35, Plesiomonas shigelliodes 302-73, Aeromonas veronii Hm21, 
Staphylococcus hominis subsp. novobiose and Aeromonas ichthiosmia CECT 4489. Four 
American Type Culture Collection (ATCC) bacteria commonly used in MIC assays were also 
tested, including, Staphylococcus aureus, Enterococcus faecalis, Escherichia coli, and 
Pseudomonas aeruginosa. Five E. coli strains cultured from wild birds were also included in this 




were also tested: Bacillus subtilis and Micrococcus luteus. Bacteria were removed from frozen 
storage and were streaked on Mueller-Hinton agar-based plates (Millipore Sigma, Germany). 
Plated bacteria were left to incubate overnight at 35 ºC. After overnight incubation, three to five 
colonies were swabbed and placed in sterile McFarland tubes and turbidity was measured. Two-
fold serial dilution between 0.015 and 128 µg/mL of fluoxetine (TCI America, Oregon) were 
added to 18mL of sterilized Mueller Hinton agar (Table 2.1). Fluoxetine concentrations used 
were as follows: 128, 64, 32, 16, 8 4, 2, 1, 0.5, 0.125, 0.06, 0.03, and 0.015 µg/mL. The 
fluoxetine-agar solution was then poured onto petri dishes and allowed to set. Bacteria 
standardized to McFarland scale of 0.5 were then plated on the fluoxetine-agar petri dishes using 
a 48-prong agar stamper. Pins on the agar stamper were dipped into each bacterial suspension 
and pressed into the fluoxetine-agar plates. Plates were then incubated in 35 ºC for 24 hours. 
MIC detection was performed by checking for growth of bacteria and compared to control plates 
(Image 2.1). Testing was performed in duplicate and MIC results were analyzed by observing at 
what concentration of fluoxetine was growth of bacteria inhibited. 
2.2.2. Fluoxetine quantification 
To confirm fluoxetine concentrations, all dilutions used in MIC testing were sub-sampled 
(1 mL) into vials and spiked with fluoxetine-d5 at a target concentration of 50 µg/L. Fluoxetine 
concentrations were then confirmed using a Vanquish UHPLC and Q-ExactiveTM HF 
Quadrupole-OrbitrapTM mass spectrometer (Thermo-Fisher). Liquid chromatography (LC) 
separation was carried out on a Kinetex 1.7µm Biphenyl LC column (100 x 2.1 mm) 
(Phenomenex, Torrance, CA) using an isocratic elution of 40% H2O: 60% acetonitrile (Fisher 
Scientific) at a flow rate of 0.2 mL/min and column temperature of 40oC. Fluoxetine and 
fluoxetine-d5 had a retention time of 1.5 min. Detailed liquid chromatography tandem mass 
spectrometry (LC-MS) parameters can be found in Appendix A. Along with fluoxetine 
quantification, percent error was calculated to identify the difference between the nominal 
concentration and the measured. Percent error was calculated by subtracting the measured 





The lowest measured concentrations were found to hold greater percent error compared to 
the higher nominal and measured concentrations (Table 2.2).  
Table 2.1| Nominal and measured concentrations of fluoxetine in agar used for MIC assays. The 




concentrations (µg/mL) Percent error 
0.015 0.0064 57.65% 
0.03125 0.0087 72.29% 
0.0625 0.0478 23.51% 
0.125 0.1023 18.17% 
0.25 0.1984 20.63% 
0.5 0.4208 15.84% 
1 0.9549 4.51% 
2 1.9941 0.30% 
4 3.9193 2.02% 
8 7.9063 1.17% 
16 15.6922 1.92% 
32 31.2306 2.40% 
64 63.3688 0.99% 




The MIC assays resulted in inhibition of growth for several bacteria at the greater 
concentrations of fluoxetine in agar (Table 2.3). All replicates besides Wild Bird E. coli 136C 
and 112A were found to be inhibited at the same concentrations. The minimum inhibitory 
concentrations of fluoxetine for the five bacteria cultured from the gut microbiome of fathead 
minnow were as follows: for Aeromonas veronii AMC 35, Aeromonas veronii Hm21 and 
Staphylococcus hominis subsp. novobiose the MIC was 32 µg/mL; For Plesiomonas shigelloides 
302-73 and Aeromonas ichthiosmia CECT 4489, the MIC was 64 µg/mL.  
As for ATCC bacteria, Staphylococcus aureus and Enterococcus faecalis held MICs of 
64 µg/mL and MIC for Escherichia coli was 128 µg/mL. Fluoxetine was ineffective against the 
ATCC Pseudomonas aeruginosa due to its ability to grow even at the highest concentration of 
* There was not enough agar left in the 128 µg/mL solution to perform the analytical 
analysis, however, by observing the other greater concentrations we can be certain a 
measured concentration would not be more than a few percentage points off from the 





the compound. Wild bird E. coli 136C, 99A, and 112A were not affected by fluoxetine even at 
the highest concentrations, however, strains 97A and 107A were inhibited at 128 µg/mL. For the 
two sensitive bacteria, Bacillus subtilis and Micrococcus luteus, the MICs were 64 and 32 
µg/mL, respectively. 
Table 2.2| MIC results depicting measured fluoxetine concentrations where inhibition of 
bacterial growth occurred. Asterisks represent the five strains cultured from the gut microbiome 
of fathead minnows. NI represents “No Inhibition” of growth. Because true concentrations were not 
measured for the nominal 128 µg/mL fluoxetine-agar mixture, ~128 is shown here. Wild Bird E. coli 





Aeromonas veronii AMC35* 31.23 
plesiomonas shigelliodes 302-73* 63.37 
Aeromonas veronii Hm21* 31.23 
Staphylococcus hominis subsp. novobiose* 31.23 
Aeromonas ichthiosmia CECT 4489* 63.37 
ATCC Staphylococcus aureus 63.37 
ATCC Enterococcus faecalis 63.37 
ATCC Escherichia coli ~128 
ATCC Pseudomonas aeroginosa NI 
Wild bird E. coli 136C ~128/NI 
Wild bird E. coli 99A NI 
Wild bird E. coli 107A ~128 
Wild bird E. coli 112A ~128/NI 
Wild bird E. coli 97A ~128 
Bacillus subtilis 63.37 
Micrococcus luteus  31.23 
 
All bacteria cultured from the gut of fathead minnows were found to be inhibited by 
fluoxetine. Fluoxetine also demonstrated inhibitory effects on ATTC bacteria except for 
Pseudomonas aeruginosa. As for wild bird E. coli strains, only two of five were found to be 
inhibited. The two sensitive bacteria used in standard MIC testing, Bacillus subtilis and 
Micrococcus luteus were found to be inhibited at ranges similar to that of the bacteria from 








Image 2.1| Images of fluoxetine inoculated petri-dishes and bacteria growth. (A) depicts 
duplicates of 32 µg/L of fluoxetine dishes next to the control, (B) 64 µg/L fluoxetine dishes and 
control, and (C) shows the 128 µg/L fluoxetine dishes and control. Controls are shown on the 





A minimum inhibitory concentration assay was conducted to assess if fluoxetine can impede 
growth of bacteria cultured from the gut microbiome of a commonly studied fish species, P. 
promelas. After a 24-hour incubation period of bacterial cells inoculated in two-fold serial 
dilutions between 0.015 and 128 µg/mL of fluoxetine-Mueller Hinton broth solution, all bacteria 
from the gut of fathead minnows were found to be inhibited by concentrations of fluoxetine 
between 32 and 64 µg/mL of fluoxetine. Several other bacterial strains included in this study that 
have been used for standard MIC testing as well as ATCC bacteria were also found to be 
inhibited by fluoxetine at similar concentrations.  
It is important to understand that the fluoxetine concentrations used in the MIC assays are not 
environmentally relevant where most studies have found fluoxetine to be between ng/L to low 
µg/L in waterbodies. However, in the context of MIC assays to determine antimicrobial like 
properties, greater concentrations are needed of the compound, typically at µg/mL, in order to 
identify bacteriostatic and bactericidal effects (Lyte et al., 2019).  
SSRIs have exhibited antimicrobial properties such as their ability to inhibit slime synthesis, 
swarming and cellular growth (Munoz-Bellido et al., 2000). Previous studies discovered similar 
results as found here including inhibition of growth of Escherichia coli and Staphylococcus 
aureus due to fluoxetine exposures (Batista de Andrade Neto et al., 2019; Cussotto et al., 2018; 
Jin et al., 2018). Batista de Andrade Neto et al., 2019 found fluoxetine to impede growth of S. 
aureus at similar concentrations as what was found in this study, while Cussotto et al., 2018 
found growth inhibition of E. coli at concentrations much greater than identified here. Munoz-
Bellido et al. (2000), found E. coli, S. aureus, and E. faecalis all to be inhibited at lower 
concentrations than were found in this study, when looking at the SSRI, sertraline. 
Speculations of the mechanisms behind SSRIs’ ability to impede growth of bacteria include 
inhibition of efflux pumps (Munoz-Bellido et al., 2000), which are pumps found on bacterial 
cells that extrude toxicants from the cell (Webber and Piddock, 2003), as well as inhibition of 
sodium symporters that are homologues to the serotonin reuptake transporter expressed on 
neuron and non-neuronal cells (Lyte and Brown, 2018). Lyte and Brown, 2018, identified two 
important biogenic amine transporters on a species of Lactobacillus which fluoxetine can block, 




bacterial homeostasis (Lyte and Brown, 2018). The discrepancies between inhibition of similar 
bacteria as described previously, could be species as well as strain specific (Lyte and Brown, 
2018), where the expression of proteins being inhibited may be found on only certain strains of 
the same species. For instance, two species within the same genus of Lactobacillus were found to 
differentially express biogenic amine transporters where L. salivarius expressed the transporters 
while L. rhamnosus did not (Lyte and Brown, 2018). In the current study, all bacteria cells 
cultured from the gut of fathead minnows were found to be inhibited by fluoxetine at lower 
concentrations than most ATCC cultures as well as E. coli strains from wild birds. This 
difference could potentially be due to fish gut microbiota being more sensitive to compounds 
with antibacterial properties.  
Based on the possibility of SSRIs impeding bacterial growth, we wanted to identify if the 
bacteria found in the gut microbiome of a standard aquatic toxicological studied organism, the 
fathead minnow, could be inhibited in vitro. This was a preliminary study conducted to enhance 
the understanding of how, in-vivo, gut bacteria may be perturbed when their host is exposed to 
fluoxetine. Because of the influential roles the gut microbiome has on its host, including helping 
with digestion, the ability to signal to the brain and immune system, and its detoxification 
mechanisms (Butler et al., 2019; Cryan and O’Mahony, 2011; Koppel et al., 2017), it is critical 
to understand how this network of microbiota is impacted when organisms, importantly for this 
work, fish, are exposed to environmental pollutants such as the pharmaceutical, fluoxetine.   
The results of this study suggest that there is a potential for fluoxetine to impede bacterial 
growth in vitro, which helps support the need to conduct an in vivo study to better assess how the 














CHAPTER 3: EFFECTS OF AQUEOUS FLUOXETINE ON THE GUT MICROBIOME 
OF ADULT FATHEAD MINNOW (PIMEPHALES PROMELAS) 
 
PREFACE 
The main objective of Chapter 3 was to assess the effect of fluoxetine on the gut microbial 
composition of fathead minnows at three different concentrations. With the understanding from 
Chapter 2 that fluoxetine can impede growth of select bacteria cultured from the gut of fathead 
minnow, it is important to understand if, in vivo, fluoxetine continues to hold antimicrobial like 
properties on the gut microbiome. By measuring alpha and beta diversity, comparing the relative 
abundance of bacteria at each concentration and exploring a network analysis associated with the 
influence of fluoxetine on the bacterial communities, we found that at the highest concentration 
of fluoxetine that fathead minnows were exposed to, held significant ramifications to the gut 
microbiome. It was also identified that the sex of the host plays an important role in the 
microbial makeup of the gut and female and male gut microbiomes were differentially affected 
by fluoxetine. Chapter 3 was prepared in a manuscript style where it will be submitted to the 
peer-reviewed journal Science of the Total Environment.  
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The microbiome of the gut is vital for homeostasis of hosts with its ability to detoxify and 
activate toxicants, as well as signal to the immune and nervous systems. However, in the field of 
environmental toxicology, the gut microbiome has only recently been identified as a measurable 
indicator for exposure to environmental pollutants. Antidepressants found in effluents of 
wastewater treatment plants and surface waters have been shown to exhibit antibacterial-like 
properties in vitro, where some bacteria are known to express proteins homologous to those that 
bind antidepressants in vertebrates. Therefore, it has been hypothesized that exposure to 
antidepressant drugs might affect gut microbiota of aquatic organisms. In this study, the common 
antidepressant, fluoxetine, was investigated to determine whether it could modulate the gut 
microbiome of adult fathead minnows. A 28-day, sub-chronic, static renewal exposure was 
performed with nominal fluoxetine concentrations of 0.01, 10 or 100 µg/L. Using 16S rRNA 
amplicon sequencing, shifts among the gut-associated microbiota were observed in individuals 
exposed to the highest concentration, with greater effects observed in females than in males. 
These changes were associated with a decrease in relative proportions of commensal bacteria, 
which can be important for the health of fish including bacteria essential for fatty acid oxidation, 
and an increase in relative proportions of pathogenic bacteria associated with inflammation. 
Results demonstrate, for the first time, how antidepressants found in some aquatic environments 















Illustration 3.1| Graphical abstract representing the gut microbial composition of fathead 







The vertebrate gut microbiome contributes to the development and function of the nervous 
system (Sampson and Mazmanian, 2015; Sharon et al., 2016). Thought of as the second brain, 
the enteric nervous system, embedded in the gastrointestinal lining, holds over 500 million 
neurons (Furness, 2006). These gastrointestinal neurons allow for communication between the 
host and gut microbiota (Carabotti et al., 2015; Forsythe and Kunze, 2012; Sampson and 
Mazmanian, 2015). Within the microbiome-gut-brain axis, gut microbiota play important roles in 
homeostasis of vertebrate hosts, for instance, regulating gastrointestinal functions, immune 
system function, and modulation of anxiolytic behavior, perception of pain and emotions 
(Amaral et al., 2008; E. A. Mayer et al., 2014; Rhee et al., 2009; Sharon et al., 2016). Some 
neurological conditions, such as Alzheimer’s disease, Parkinson’s disease, autism and 
depression, can be, at least in part, attributed to dysbiosis or deregulation of the gut microbiome 
(Harach et al., 2017; Kim et al., 2018; Naseribafrouei et al., 2014; Strati et al., 2017). The 
majority of such research has focused on mammals, while studies of the relationship between gut 
microbiomes of fishes and neurological events are still lacking (Butt and Volkoff, 2019). 
However, it has been found that the gut microbiome can influence the hypothalamic-pituitary-
inter-renal axis (HPI) as well as the stress response in fish, which in turn can affect immune 
system function, feeding behaviors and overall homeostasis (Butt and Volkoff, 2019; Davis et 
al., 2016). 
Microbiomes in guts of animals can influence major neurotransmitters. The essential 
neurotransmitter, serotonin (5-hydroxy-tryptamine, 5-HT), can be regulated by certain enteric 
microbes (Turcibacter sanguinis and Lactobacillus salivarius) perhaps stimulating host 5-HT 
biosynthesis (Fung et al., 2019; Lyte and Brown, 2018; Yano et al., 2015). Recently, several 
studies have assessed how Selective Serotonin Reuptake Inhibitors (SSRIs) as well as other 
psychoactive drugs affect gut microbiota of rodents with the aim to elucidate possible effects on 
humans. Findings include changes in the absolute and relative gut microbiome composition and 
antimicrobial-like properties of fluoxetine on certain bacteria including Turcibacter sanguinis, 
Lactobacillus rhamnosus, Escherichia coli as well as the family Peptostreptococcaceae 




Consumption of antidepressants is continuously increasing worldwide (OECD, 2017) and 
these compounds are now commonly observed in wastewater effluents and downstream aquatic 
environments at concentrations of nanograms to micrograms per liter (Ding et al., 2017; Kolpin 
et al., 2002; Kreke and Dietrich, 2008; Schultz et al., 2011). Among prescription antidepressants, 
fluoxetine is a model compound for studying the toxicological effects of antidepressants. 
Fluoxetine (under the trade name Prozac®) is one of the most prominently used SSRIs (Luo et 
al., 2020). After transformation in the body, less than 10% of fluoxetine is excreted in its 
unchanged, more lipophilic state, while 20% is excreted as its primary metabolite, norfluoxetine 
(Silva et al., 2012). Concentrations of fluoxetine have been found at 0.012 µg/L in freshwater 
streams and 0.09 µg/L in wastewater effluent in North America (Brooks et al., 2003a; Kolpin et 
al., 2002; Metcalfe et al., 2010; Silva et al., 2012a). Within raw sewage concentrations of 0.01 to 
3.5 µg/L have been reported (Ding et al., 2017). Fluoxetine has also been detected in tissues of 
wild fish between 0.02 and 1.58 ng/g (Brooks et al., 2005; Chu and Metcalfe, 2007; Schultz et 
al., 2010). Bioconcentration of fluoxetine in the Japanese medaka (Oryzias latipes) (Paterson and 
Metcalfe, 2008) and Daphnia magna (Ding et al., 2017) leads to concerns for ecotoxicological 
risks to aquatic animals.   
There have been multiple studies focusing on toxicological endpoints of SSRIs on aquatic 
organisms including reproduction, physiology, and behavior. Findings suggest reductions in 
behaviors related to aggression and anxiety, modulating the predator-prey response, suppression 
of appetite, and stimulation of the hypothalamic-pituitary-gonadal (HPG) and the HPI axes 
contributing to reproduction impairments of fish (Brooks et al., 2003a; McDonald, 2017; 
Polverino et al., 2021). Until now, no research has been conducted to determine effects of SSRIs 
on the gut microbiome of fishes. 
To investigate how fluoxetine might modulate the microbiome of the gut of the fathead 
minnow (Pimephales promelas), a sub-chronic aqueous exposure of fluoxetine ranging from an 
environmentally relevant concentration, 0.01 µg/L, to a sub-lethal concentration of 100 µg/L was 
conducted. The objectives of this study were to: (1) Identify potential differences in the gut 
microbiome of male and female fathead minnows; (2) Detect effects of fluoxetine on the 
abundance and diversity of the gut microbiome of fathead minnows; and (3) Identify any sex-





3.2. Materials and methods 
3.2.1. Fish husbandry, aqueous exposure and dissection 
Adult fathead minnows, approximately 6 months old, were obtained from the Aquatic 
Toxicology Research Facility at the University of Saskatchewan. A density of five fish, both 
males and females, were randomly assigned to a 20-L tank and tanks were randomly assigned a 
fluoxetine concentration (n = 25 per group, 5 fish per tank, 5 tanks per group, 4 groups). Tanks 
were aerated using air pumps and dechlorinated water was sourced from the municipal 
Saskatoon water supply. Fluoxetine hydrochloride (ThermoFisher Scientific, Waltham, MA) was 
dissolved in water to make a stock solution from which working solutions were then made. 
Nominal exposure concentrations consisted of a control group (0 µg/L), low concentration group 
(0.01 µg/L), middle concentration group (10 µg/L), and high concentration group (100 µg/L). 
After one week of acclimation, fluoxetine-treated water was added to each tank. Fish were fed 
twice daily with 2 mg of blood worms and water temperatures were consistently monitored 
(average = 22 ºC ± 0.7). Ammonia, pH, nitrites, nitrates and dissolved oxygen were monitored in 
each tank and light to dark ratio was 16:8 according to OECD 229 guidelines (OECD, 2009). 
This was a static renewal test where tanks were siphoned daily where two-thirds of the tank 
solution was replaced with freshly prepared fluoxetine treated water. Water samples were taken 
twice daily, before and after water renewal, for analysis of fluoxetine concentrations.  
After 28 days, fish were anesthetized in MS-222 and mass and length were measured. Fish 
were then euthanized by decapitation and whole gut including tissue and gut contents were 
collected using sterile techniques. When possible, sex of fish was recorded. All samples were 
placed in sterile cryovials and held in liquid nitrogen before being placed in a -80 ºC freezer until 
analyses. Maintenance of fish was in line with the animal use protocols (Protocol #20090108) 
approved by the Animal Research Ethics Board at the University of Saskatchewan.  
Overall fish health was determined following Fulton’s condition factor (K) calculated from 








3.2.2. Quantification of aqueous fluoxetine 
Stock solutions of fluoxetine and fluoxetine-d5 (ThermoFisher Scientific, Waltham, MA) 
were made in HPLC grade methanol (Fisher Scientific) at 100 mg/L. A seven-point calibration 
curve ranging from 0.5 to 500 µg/L and spiked with 50 µg/L fluoxetine-d5 was used for 
quantification by isotope dilution (linearity > 0.999 for all analyses). The 10 and 100 µg/L 
exposure solutions were sub-sampled (1 mL) directly into LC vials and spiked with fluoxetine-
d5 at a target concentration of 50 µg/L for analysis. Control and 0.01 µg/L exposure solutions 
were sub-sampled (40 mL) into 45 mL falcon tubes, spiked with fluoxetine-d5, and extracted 
using solid phase extraction (SPE) OASIS™ HLB cartridges (6cc, Waters Corporation, Milford, 
MA). After pre-conditioning with methanol followed by water, 40 mL of water samples were 
drawn through at approximately 5 mL min-1, cartridges were then vacuum dried, and eluted with 
2 × 3 mL fractions of methanol (combined). Extracts were evaporated to dryness under nitrogen 
in a water bath at 40 oC, and reconstituted in 0.5 mL of 50:50 MeOH-H2O into amber LC vials. 
Fluoxetine was quantified using a Vanquish UHPLC and Q-ExactiveTM HF Quadrupole-
OrbitrapTM mass spectrometer (Thermo-Fisher). LC separation was achieved with a Kinetex 1.7 
µm Biphenyl LC column (100 x 2.1 mm) (Phenomenex, Torrance, CA) by gradient elution with 
95% water + 5% methanol (A) and 100% methanol (B), both containing 0.1% formic acid at a 
flow rate of 0.2 mL min-1 and column temperature of 40 oC. The gradient method started at 
10%B, ramping linearly to 100%B over 7 min, held for 1.5 min, and returning to starting 
conditions for column re-equilibration between 8.5 to11 min. Further details on LC-MS 
parameters can be found in Appendix A. All samples were analyzed for the 100 and the 10 µg/L 
exposure groups while a subset (n=11, per group, Table 3.1) of the samples were analyzed for 
the 0.01 µg/L and control samples using SPE techniques. 
 
3.2.3. Extraction of Bacterial DNA and 16S rRNA metagenomics  
DNA was extracted from whole intestines using the DNeasy PowerSoil Kit (Qiagen Inc., 
Mississauga, ON). Concentrations of DNA were measured using a Qubit 4 Fluorometer and 
dsDNA HS assay kit (ThermoFisher Scientific, Waltham, MA). The V3-V4 hypervariable region 
of the bacterial 16S ribosomal RNA gene was amplified by polymerase chain reaction (PCR) 




GGACTACNVGGGTWTCTAAT-3′). PCR products were checked by agarose gel 
electrophoresis and no bands were observed for blank controls. Products were then purified using 
the QIAquick 96 PCR Purification (Qiagen Inc., Mississauga, ON) following manufactures 
instructions. Library preparation and next generation sequencing (NGS) was conducted 
following procedures previously published by DeBofsky et al. (2020). Briefly, The NEBNext® 
DNA Library Prep Master Mix Set for Illumina® (New England BioLabs Inc., Whitby, ON) was 
used for library construction, and prior to sequencing, quantification of samples was conducted 
using the Library Quant kit for Illumina®. Sequencing was run on an Illumina® MiSeq sequencer 
(Illumina, San Diego, CA).  
3.2.4. 16S rRNA metabarcoding and bioinformatics 
Bioinformatics analyses were conducted under the QIIME2 v. 2020.10 environment (Bolyen 
et al., 2019). Adapters were trimmed using Trimmomatic (Bolger et al., 2014). After 
demultiplexing, amplicon sequence variants (ASV) were denoised and extracted using DADA2 
(Callahan et al., 2016) where low quality and primer regions were removed by truncating 
forward reads at 260bp, and reverse reads at 220bp. Taxonomy was assigned using the feature 
classifier, VSEARCH (Rognes et al., 2016), against SILVA 132 reference database (Bokulich et 
al., 2018; Quast et al., 2013). All unassigned and nonbacterial ASVs were then removed, and 
alpha rarefaction was performed where a sampling depth of 11,125 was decided based on the 
ability to maximize the depth threshold while minimizing sample loss (Estaki et al., 2020). In 
total, 73 samples were retained after rarefaction including 31 males and 42 females. Of the 
males, there were 8 in the control group, 8 in the low group, 6 in the middle group and 9 in the 
high group. Of the females there were 11 within the control group, 11 in the low group, 9 in the 
middle group and 11 in the high group.  
3.3. Statistics 
All statistical analysis were conducted in R Statistical Language v 4.0.3 (R Core Team, 
2020).  Normal distribution and equal variance were first determined using a quantile-quantile 
plot (Q-Q plot), residuals vs fitted plots, Shapiro-Wilk test and a Levene’s test (Borcard et al., 
2011). To determine fitness of fish, sexes were separated, and K was identified (equation 1) for 
each fish. If the assumption of a normal distribution was met, an analysis of variance (ANOVA) 




If normal distribution parameters were not met, data was log transformed before running a 
Levene’s test to determine equal variance and an ANOVA was then performed. Alpha diversity, 
beta diversity and relative and differential abundance of ASVs were analyzed with Phyloseq v 
1.32.0 (McMurdie and Holmes, 2013).  
For parametric testing, a two-sided Student’s t-test was applied when evaluating differences 
between sexes and an ANOVA with a Tukey’s HSD was performed to evaluate differences 
between exposure groups. If assumptions of equal variance were not met while still being 
normally distributed, a Welch’s t-test was run for sex differences. The non-parametric tests 
performed when normality was not met included a Wilcoxon rank sums test used to compare 
differences in alpha diversity between sexes and a Kruskal-Wallis test with a Dunn’s post-hoc 
test used for alpha diversity between exposure groups. To compare beta diversity metrics for 
both sex and exposure group, a multivariate analysis of variance with permutation 
(PERMANOVA) was conducted along with testing for homogeneity of multivariate dispersion 
(PERMDSIP) (Anderson, 2001; Dalgaard, 2008; McArdle and Anderson, 2001; Xia et al., 2018). 
Because sex was found to explain portions of alpha and beta diversity, analyses comparing 
exposure groups were conducted by separating the sexes. To determine differential abundance of 
taxa, a linear discriminant analysis (LDA) effect size (LEfSe) was performed (Segata et al., 
2011). Neighborhood selection relationships between ASVs (Meinshausen and Bühlmann, 2006) 
were constructed by the SPIEC-EASI package (Kurtz et al., 2015). Correlations between relative 
abundance of ASV and aqueous concentration of fluoxetine were confirmed to be robust if the 
adjusted false discovery rate (FDR) was statistically significant (PFDR < 0.05). The network was 
displayed and analyzed with Cytoscape V3 (Otasek et al., 2019). 
3.4. Results 
3.4.1. Aqueous concentration of fluoxetine and fitness of Fish 
Daily, mean aqueous concentrations after each water change and 24 hours after each 
renewal were measured (Table 3.1). Measurements of fluoxetine in water confirmed that 
concentrations consistently decreased between renewal periods (24 hr). Mean (SD) pH of water 
was 7.9±0.2 throughout the exposure. Condition factors of both female (Appendix B.A, ANOVA 




significantly affected by exposure to fluoxetine. There were two mortalities during the fish 
exposure, however, not attributable to fluoxetine itself.  
 
Table 3.1| Mean and standard deviation (SD) of aqueous concentrations of fluoxetine right after 
each water-change (1st sampling), 24 hours after renewals (2nd sampling) and predicted plasma 
concentration based on the fish plasma model and linear equation model identified by Margiotta-
















High 100 90.1 ± 8.8 (n=29) 63.2 ± 9.2 (n=6) 1201.3 
Middle 10 8.0 ± 0.9 (n=29) 4.2 ± 1.0 (n=6) 29.9 
Low 0.01 0.006 ± 0.002 (n=8) 0.004 ± 0.0006 (n=3) 0.02 
Control 0 0.002 ± 0.001 (n=8) 0.0008 ± 0.0002 (n=3) 0.006 
 
3.4.2. Host sex shaped gut microbiome 
Female and male fish exhibited distinct compositions of gut microbial communities. In 
total, 386 ASVs were recovered for both female (n = 42) and male fishes (n = 31), with 5.2 
million sequenced reads. 77.7% of reads survived after quality checking, filtering, merging and 
non-chimeric cleaning (Appendix F). Rarefaction at an even sequencing depth of 11,125 
sequences per sample retained 377 ASVs (Appendix C). Alpha-diversities (Faith’s Phylogenetic 
Diversity and Shannon diversity) of the gut microbiomes of females were greater than those of 
males (Wilcoxon one-tailed signed rank test, p < 0.01, Figure 3.1A and B). Beta-diversities 
(unweighted and weighted UniFracs distances) found significant separations between male and 
females (PERMANOVA, unweighted UniFrac distance, F = 11.96, p = 0.001, Figure 3.1C; 
weighted UniFrac distance, F = 4.25, p = 0.006, Figure 3.1D). Dispersion of unweighted UniFrac 
distances was heterogeneous while weighted values were homogenous between female and male 
fish (unweighted UniFrac distance; PERMDSIP test, F = 7.45, Pperm = 0.008, weighted UniFrac 
distance; PERMDISP test, F = 0.03, Pperm = 0.86). Fifty-two bacterial families were differentially 




males compared to female fish (Figure 3.1E, LEfSe test, p < 0.05 and log10 transformed LDA 
score > 2). Within the top 10 most abundant families, Barnesiellaceae, Chitinibacteraceae, 
Rubritaleaceae, Shewanellaceae, and Vibrionaceae, were significantly differentially abundant 
between male and female fish (Figure 3.1F). Female fish hosted a more complex microbial 
network than male fish where females had, 209 nodes, 562 edges and 5,378 neighbors and males 
had, 171 nodes, 339 edges and an average of 4,238 neighbors (Neighborhood Selection Network 
analysis, Figure 3.2A and Appendix L). The microbial Network of males contained fewer nodes 







Figure 3.1| Alpha diversity matrices comparing female (n = 42) and male (n = 31) fish: (A) Faith Phylogenetic Diversity; p = 
6.127e-06 and (B) Shannon Diversity Index; p = 0.02. (C) Unweighted UniFrac and (D) Weighted UniFrac depicting the 
distances in microbial composition between female and male fish; Unweighted PERMANOVA; F = 11.96, p = 0.001, 
Weighted PERMANOVA; F = 4.25, p = 0.006. (E) Cladogram of taxonomic levels from a LEfSe analysis. Taxa in red are 
differentially and greater expressed in female fish and those in green are greater expressed in males. (F) Boxplot depicting 
relative abundant families found to be differentially expressed in females versus males. Significant correlations: *, p < 0.05; 







Figure 3.2| Neighborhood Selection Network analyses indicating an increase of fluoxetine to be 
significantly correlated to major clusters of class level taxa. Clusters from (A) female fish contain 
more nodes and thus higher alpha diversity. Clusters from (B) male fish hold less nodes representing 
less abundance of class level taxa. Red lines indicate a negative correlation between fluoxetine and 
abundance of classes while dark blue lines indicate a positive correlation. Light blue lines represent an 






3.4.3. Female gut microbiome response to fluoxetine exposure 
 Fluoxetine caused weak trends on select metrics of alpha diversity in female fish within 
the high exposure group. Faith PD showed greater abundance in the high (100µg/L) compared to 
the middle (10µg/L) exposure group, p < 0.05. No significant difference was observed between 
the control group and the high group, nor between the control group and the low and middle 
exposure groups when observing alpha diversity metrics (Figure 3.3A & B).   
 Exposure to aqueous fluoxetine significantly altered the relative percent composition of 
the gut microbiome of female fish (PERMANOVA test: unweighted distances, F = 4.39, p = 
0.001; weighted distances: F = 5.38, p = 0.001, Figure 3.3C & 3D). Beta diversity of the high 
exposure group was significantly different from that of all other groups (Table 3.2). No 
significant differential beta diversity matrices were found between control, low, and middle 
exposure groups within female fish. Five family level taxa were negatively associated with an 
increase in fluoxetine concentration while fifteen were positively correlated (Figure 3.3E). 
Several bacterial families were significantly different when comparing each exposure group to 
the control group (LEfSe test). Akkermansiaceae, Peptostreptococcaceae and Barnesiellaceae 
show a significant decrease in abundance in the high group while there was a significant increase 
in Rubritaleaceae, Chitinibacteraceae, Shewanellaceae, Flavobacteriaceae, and Aeromondaceae 
in the high group compared to the control group. Abundance of Akkermansiaceae was also 
significantly less in the low group compared to the control group (Appendix G). Classes in the 
largest cluster of the female gut microbial network were significantly correlated with increasing 
concentrations of fluoxetine (Figure 3.2A), which is comparable with the heatmap of family 
level taxa (Figure 3.3E).  
 
Table 3.2| Pairwise PERMANOVA and PERMDISP of Weighted and Unweighted UniFrac 
distances to determine significant differences of gut microorganisms between exposure groups 




Weighted UniFrac Unweighted UniFrac 
PERMANOVA PERMDISP PERMANOVA PERMDISP 
Female Ctrl-Low F = 0.68, p = 0.52 p = 0.76 F = 1.06, p = 0.34 p = 0.28 




 Ctrl-High F = 8.16, p = 0.002* p = 0.52 F = 6.36, p = 0.001* p = 0.31 
 Low-Mid F = 0.88, p = 0.40 p = 0.57 F = 1.7, p = 0.10 p = 0.0008* 
 Low-High F = 9.35, p = 0.001* p = 0.32 F = 7.28, p = 0.001* p = 0.80 
 Mid-High F = 9.56, p = 0.001* p = 0.078 F = 9.43, p = 0.001* p = 0.08 
Male Ctrl-Low F = 1.5, p = 0.23 p = 0.99 F = 0.92, p = 0.396 p = 0.19 
 Ctrl-Mid F = 3.2, p = 0.041* p = 0.8 F = 0.65, p = 0.53 p = 0.12 
 Ctrl-High F = 10.0, p = 0.001* p = 0.01* F = 1.55, p = 0.183 p = 0.04* 
 Low-Mid F = 2.6, p = 0.049* p = 0.81 F = 0.62, p = 0.661 p = 0.52 
 Low-High F = 7.7, p = 0.002* p = 0.01* F = 1.98, p = 0.136 p = 0.006* 
 Mid-High F = 10.3, p = 0.001* p = 0.05 F = 1.7, p = 0.187 p = 0.009* 
 
3.4.4. Male gut microbiome response to fluoxetine exposure 
The gut microbiome composition of male fish was found to be altered by fluoxetine 
exposure. Alpha diversity (Faith PD and Shannon Diversity indices) of the microbial 
communities in guts of males were not significantly different among treatments (Kruskal-Wallis 
test, p > 0.05, Figure 3.3F & 3.3G). However, fluoxetine did significantly alter the matrix of 
weighted UniFrac distances among exposure groups (PERMANOVA, F = 7.14, p = 0.001, 
Figure 3.3H). No significant differences were identified for Unweighted UniFrac distances for 
male fish (PERMANOVA, F = 1.41, p = 0.218, Figure 3.3I). Pairwise PERMANOVAs indicate 
the significant differences in the weighted UniFrac were between the high exposure group and all 
other groups as well as between the middle exposure group and all other groups (Table 3.2). 
Homogeneity of multivariate dispersion was found significant for the weighted UniFrac between 
control and high as well as low and high exposure groups (PERMDISP, p = 0.01, Table 3.2). 
Proportions of thirteen abundant families in the male gut microbiome were significantly 
correlated with aqueous concentrations of fluoxetine, five being negatively correlated and eight 
being positively correlated (Figure 3.3J). A LEfSe analysis found that within the top ten most 
relative abundant families, seven were differentially abundant when comparing each group 
separately to that of the control. Akkermansiaceae, Erysipelotrichaceae and 
Peptostreptococcaceae were more abundant in controls compared to the high exposure group 
while Vibrionaceae was more abundant in the high exposure group compared to the control 
(Appendix H). Tannerellaceae and Akkermansiaceae were more abundant in the middle group 




compared to control. The Neighborhood Selection Analysis revealed classes of taxa in the largest 









The present study focused on whether fluoxetine can affect the gut microbiome of the fathead 
minnow in a sub-chronic aqueous exposure. Structures of male and female gut microbiomes 
were found to be significantly distinct while fluoxetine caused changes in community structure 
of both sexes when exposed to the highest concentration. Concentrations to which fish were 
exposed during this study that were close to the environmental quality standard values of interest 
(European Commission, 2000) for fluoxetine (0.01 μg/L) did not significantly alter the alpha-
diversity or overall composition of gut microbiome. However, the high exposure concentration 
(100 µg/L), significantly altered alpha and beta diversity of the gut microbiome. The high 
exposure level was predicted to cause a plasma concentration of 1201.3 µg/L (Table 3.1; 
Predicted Plasma Concentrations), which is greater than the human therapeutic range (HTPC, 91-
302 µg/L) (Margiotta-Casaluci et al., 2014; Pan et al., 2018)  
Although the concentration of fluoxetine found to affect the gut microbiome in this study was 
substantially greater than concentrations observed in aquatic environments and greater than the 
HTPC, there is still relevance for understanding how this data can be used for cross-species 
extrapolation to predict similar effects on the evolutionarily conserved molecular targets in both 
Figure 3.2| Alpha diversity matrices: Faith Phylogenetic Diversity for (A) females and (F) males, 
and Shannon Diversity Index for (B) females and (G) males. Beta diversity matrices: weighted 
UniFrac for (C) females and (H) males. Unweighted UniFrac distance matrices for (D) females and 
(L) males. Heatmaps (E, Females & J, males) depicting the correlation between proportion of 
families and the fluoxetine concentration fish were exposed to. Abundance of family level taxa are 
illustrated by the greyscale where black indicates higher abundance and white indicates lower 
abundance. Fish are sorted into their fluoxetine concentration groups which can be found vertically 
(ctrl, low, mid, high). A Pearson’s correlation coefficient representing the association between 
fluoxetine exposure concentration and the proportion of families present can be found on the red-
blue scale where red relates to a positive correlation and blue to a negative correlation between the 
two variables. Heatmaps for genus and ASV levels can be found in Appendices J and K. Significant 






fish and mammals (Margiotta-Casaluci et al., 2014; Rand-Weaver et al., 2013). It also 
demonstrates a plausible mechanism of action for SSRIs to cause changes in the microbiome of 
vertebrates via potentially binding to the homologous transporter proteins expressed by select 
bacteria cells (Lyte et al., 2019; Lyte and Brown, 2018). 
Abundant phyla identified in this study were consistent with other studies done on fathead 
minnow, including the two most prominent phyla Fusobacteria and Proteobacteria to be 
dominant within both males and females (Appendix I.A & B) (Bridges et al., 2018; Debofsky et 
al., 2021; DeBofsky et al., 2020; Narrowe et al., 2015). These two phyla are also found to 
dominate in the zebrafish gut as well (Roeselers et al., 2011). Bacteroidetes and Firmicutes, the 
third and fourth most dominant phyla within fathead minnow in this study, are also prevalent in 
other fish gut microbiomes including rainbow trout, pinfish, silver perch, mummichog, and black 
sea bass (Colston and Jackson, 2016; Givens et al., 2015). Tryptophan metabolism pathways 
have been found to be enriched in these four dominant phyla in the fish gut (Kaur et al., 2019), 
which suggests that the fish gut microbiome can produce neuroactive compounds influencing the 
gut-brain axis (Bastiaanssen et al., 2020).  
When comparing the differences between sexes in the control exposure groups only, as well 
as comparing males and females within each dosage group, significant differences were 
identified observing diversity matrices. This could be due to fluoxetine differentially impacting 
male and female gut microbiomes; thus, it is necessary to separate the sexes to better assess how 
fluoxetine influences the gut microbiome. In other studies sex has also been identified to play a 
major role in composition of the gut microbiome (Bolnick et al., 2014; DeBofsky et al., 2020; 
Gao et al., 2018; Jašarević et al., 2016; Lozano et al., 2018) further demonstrating the importance 
of separating males and females when analyzing microbiome data where, lower alpha diversity 
in males has been reported in fish, mice, and humans (de la Cuesta-Zuluaga et al., 2019; 
DeBofsky et al., 2020; Li et al., 2016; Yurkovetskiy et al., 2013). It has been postulated that 
hormonal changes during puberty can determine the structure of the gut microbiome potentially 
through androgen receptor activity (de la Cuesta-Zuluaga et al., 2019; Markle et al., 2013; 
Yurkovetskiy et al., 2013). Within families enriched in the female fish gut microbiome in this 
study, Burkholderiaceae and Bacillaceae are predicted to have a substantial capability in 




2019), found in both sexes. This finding indicates that some bacteria, potentially more 
predominant in female fish, may be more affected by tryptophan and serotonin levels within the 
body.  
In general, there may be two major direct routes of interaction between fluoxetine and gut 
microbiota, including, antimicrobial potential of fluoxetine and the interaction with metabolite 
pathways generating neuroactive compounds (Ait Chait et al., 2020; Zhang et al., 2021). Results 
of this study suggest antimicrobial action of fluoxetine may have caused significant alteration of 
gut microbiomes of both females and males, which resulted in changes in structures of the 
microbial community in guts of fish exposed to the highest concentration. Furthermore, negative 
relationships between concentrations of fluoxetine and proportion of taxa (ASV) were observed 
in both female and males (Figure 3.2A & B, Figure 3.3E & J). Relative proportions of 
Akkermansiaceae and Peptostreptococcaceae observed here were negatively correlated with 
aqueous concentrations of fluoxetine, consistent with the antimicrobial activity of 
antidepressants found in previous studies (Ait Chait et al., 2020; Zhang et al., 2021). It is 
hypothesized that the proposed antimicrobial capabilities of SSRIs is a result of binding to 
homologous serotonin reuptake transporters on bacterial cells. In vitro colonization of certain 
bacteria, such as Lactobacilli and E. coli, were found to be inhibited when exposed to fluoxetine 
due to its ability to block a biogenic amine transporter found on some bacterial cells, 
homologous to that of the serotonin reuptake transporter (SERT) in vertebrates (Cussotto et al., 
2018; Lyte and Brown, 2018).  
The representative bacterial species in human gut microbiomes are sensitive to non-antibiotic 
drugs, such as antidepressants (Maier et al., 2018), which suggests that alterations of gut 
microbiota by fluoxetine might influence fitness of the host. The species Turcibacter sanguinis, 
for instance, within the family Erysipelotrichaceae, found to be negatively associated with 
fluoxetine in males in this study, has recently been identified to play an important role in 
serotonin signaling, holds ortholog transporters to SERT and has previously been found to be 
inhibited by SSRIs (Fung et al., 2019; Jones et al., 2020). Changes in the presence of 
Akkermansia muciniphila, in the family Akkermansiaceae found to also be negatively affected by 
fluoxetine in this study, can adversely affect host health. An increase in A. muciniphila is linked 




metabolic alterations, and potential disease progression (Schneeberger et al., 2015; Sivixay et al., 
2021). Importantly, Akkermansiaceae can regulate host serotonin through an outer membrane 
protein, Amuc_1100 (Wang et al., 2021).  
Due to the distinct composition of gut microbiome between female and male fish, response to 
fluoxetine exposure presented sex-specific patterns at each taxa-level. Clostridiales (Phylum 
Firmicutes), found here to be significantly less in females exposed to the greatest concentration 
of fluoxetine, compared to controls, has been found to respond to host serotonin fluxes 
suggesting it might have transporters similar to that of SERT (Fung et al., 2019). Abundances of 
Proteobacterial families: Shewanellaceae and Aeromondaceae in females and Vibrionaceae in 
males were positively correlated with concentrations of fluoxetine and have been found to be 
associated with anxiety, inflammation, and pathogenesis, respectively (Colwell and Grimes, 
1984; De Palma et al., 2017; Reid et al., 2008; Song et al., 2016). When exposed to the greatest 
concentration of fluoxetine, there were several more families altered in abundance in females 
compared to males (Figures 3.3E & J, Appendices G & H). The greater effect of fluoxetine on 
females could be a result of sex-hormones playing a role in the microbial makeup. Due to a 
greater alpha diversity in females, there is a larger potential for fluoxetine to influence these 
bacterial communities. It has been identified that composition of microbial composition of guts 
of males and females might be affected differently by pharmaceuticals (Sinha et al., 2019).   
Results of previous studies have revealed that fluoxetine can cause anxiolytic behavior, 
appetite suppression, reproduction impairments and modulation of the predator-prey response in 
fish (Lister et al., 2009; McDonald, 2017; Mennigen et al., 2010; Pelli and Connaughton, 2015; 
Weinberger and Klaper, 2014). However, similar to this study, some of the adverse effects 
identified in those exposures occurred at concentrations greater than those typically observed in 
the environment and exposed for relatively short durations of less than 35 days. Due to 
continuous release of pharmaceuticals into aquatic environments and their ability to 
bioconcentrate (Pan et al., 2018), chronic and multigenerational studies at environmental relevant 
concentrations would be of value (Polverino et al., 2021; Silva et al., 2015; Tan et al., 2020). A 
future chronic study should be conducted at environmentally relevant concentrations to reveal 
whether the presence of fluoxetine may perturb the gut microbiome of fish long-term. Work 




effects of fluoxetine across vertebrate species that hold conserved molecular pharmaceutical 
targets (Rand-Weaver et al., 2013). Finally, functional capabilities of gut microbiota perturbed 
by fluoxetine through integrated multi-omics techniques would be valuable to further understand 
the connection between the microbiome and its host (Whon et al., 2021). For example, if we are 
able to understand which microbes are inhibited in colonization and growth, we can further 
identify what function these biota hold in the body using transcriptomics, proteomics as well as 
metabolomics techniques. These approaches allow us to identify the transcription of DNA to 
RNA (transcriptomics), the translation of RNA to proteins, essential for cell and tissue growth 
(proteomics), and the metabolites that form after cellular processes (metabolomics). These 
techniques are valuable in identifying the function of the microbial communities making up the 
microbiome and allow us to further appreciate and utilize the microbiome in the context of risk 
assessment. 
3.6. Conclusions 
Shifts in dominant taxa in the gut microbiomes of fathead minnow (P. promelas) were 
observed in individuals exposed to the greatest concentration of fluoxetine (100 µg/L). The 
lowest (0.01 µg/L), which was more representative of environmentally relevant concentrations, 
and middle concentration (10 µg/L) did not significantly alter the gut microbiomes of fathead 
minnows. This study demonstrated that fluoxetine can affect the gut microbiome, yet at 
concentrations greater than observed in the environment. Due to evolutionarily conserved 
transporter proteins in vertebrates and microbiota, it can be predicted that certain gut microbiota 
in other vertebrates may be impacted by fluoxetine as well. Future long-term studies will help 
determine if fluoxetine, at environmental relevant concentrations, can affect the gut microbiome 
of fish. A reduction in several commensal bacteria and an increase in pathogenic and 
inflammatory related taxa indicates that host health may be perturbed long term. The gut 
microbiome plays a crucial role in host immune and nervous systems; thus, it is pertinent to 
establish an understanding of the types of microbiota colonizing the gut and their functional 





































4.1.Project focus and objectives 
With the knowledge of a microbiome-gut-brain-axis, where a bi-directional influential 
relationship takes place between the brain and the microbial communities living within the gut, it 
is critical to better understand how these microbes are influenced when their host is exposed to 
toxicants. Only in recent years has the importance of the gut microbiome become understood in 
the field of ecotoxicology (Evariste et al., 2019). To our knowledge this is the first study 
conducted to determine the impact of antidepressants, found downstream of wastewater 
treatment plants, on the gut microbiome of a commonly studied fish, the fathead minnow 
(Pimephales promelas). The focus of this research was to heighten an understanding of the 
effects on the gut microbiome when its host is exposed to a xenobiotic and to give stronger 
evidence of the importance of microbiome studies in the field of ecotoxicology. The main 
objectives of this study were to better understand if (1) if the antidepressant, fluoxetine, can 
impede growth of bacterial cells, cultured from the gut of fathead minnows, in vitro, and, using 
16S rRNA metabarcoding techniques, (2) determine if differences exist between the gut 
microbiome of female and male fathead minnow, (3) identify if fluoxetine can cause dysbiosis of 
the gut microbiome when fish are exposed to three different concentrations of fluoxetine, and (4) 
compare sex-specific effects of fluoxetine on the gut microbiome.  
4.2.Summary of findings 
4.2.1. Minimum inhibitory concentrations 
The basis of running a minimum inhibitory concentration assay was established due to 
the understanding that some bacterial cells, including commensal bacteria living within the gut 
microbiome, express homologous proteins to those of the neturotransmitter:sodium symporters, 
such as the selective serotonin reuptake transporter found on numerous types of cells in 
vertebrates (Lyte and Brown, 2018; Zhou et al., 2009). Previous studies have been conducted, 
specifically looking at mammalian commensal microbiota where SSRIs can bind to these 
transporters on bacterial cells, impeding their growth (Bohnert et al., 2011; Cussotto et al., 2018; 
Lyte and Brown, 2018; Munoz-Bellido et al., 2000). Bacteria previously cultured from the gut 
microbiome of fathead minnow were exposed to a dilution series of fluoxetine ranging from 
0.015 to 128 µg/mL. After overnight inoculation, cell growth was determined, concluding that 




fluoxetine. It was previously hypothesized that the potential reasons for inhibition of growth are 
due to the efflux pump inhibition by these SSRIs and the potential that these bacterial cells 
contain the sodium symporters homologous to SERT which SSRIs can than bind to (Lyte and 
Brown, 2018; Munoz-Bellido et al., 2000). The results from this preliminary study established a 
basis to better understand if such mechanisms of growth inhibition can occur in vivo when the 
host organism for these microbes is exposed to fluoxetine. Thus, a second study was conducted 
exposing fathead minnow to select concentrations of fluoxetine. 
4.2.2. Analyzing sex differences and the effects of fluoxetine on the gut microbiome of 
fathead minnow 
Fluoxetine was found to have a significant effect on the gut microbiome of fathead minnows 
at the highest exposure concentration (nominal concentration of 100 µg/L) where the microbial 
makeup was found to be significantly shifted away from the other groups. After a baseline 
understanding that fluoxetine can inhibit bacterial growth in vitro, a fish study was conducted 
exposing fathead minnows to three different concentrations of fluoxetine as well as a control. 
After 28 days, fish were euthanized, GI tracts were extracted, DNA extraction, amplification, 
purification and sequencing was run, and bioinformatics was then performed to identify if 
fluoxetine can influence the microbial community structure of the gut microbiome of fathead 
minnows. It was determined that not only did fluoxetine induce changes in the microbiome at the 
highest concentration, but the gut microbiome of female and male fish were found to be distinct. 
The female gut microbiome was found to have greater alpha diversity, and the types of 
microbiota making up these communities were found to be separating away from each other 
when observing beta-diversity. These findings coincide with other studies, demonstrating that the 
makeup and abundance of bacteria are significantly different when comparing male and female 
hosts (Bolnick et al., 2014; DeBofsky et al., 2020; Gao et al., 2018; Jašarević et al., 2016; 
Lozano et al., 2018). The differences found between sexes may be due to hormonal changes 
where the gut microbiome has been found to be influenced by androgen receptor activity (de la 
Cuesta-Zuluaga et al., 2019; Markle et al., 2013; Yurkovetskiy et al., 2013). Due to differences 
in microbial makeup of the gut microbiome of male and female fish, it was critical to separate 
the two sexes when identifying if fluoxetine impacted these microbial communities. Alpha 




for either sex. Interestingly, the variability in alpha diversity within male fathead minnows was 
quite prevalent in the highest exposure group, where fluoxetine may have caused inconsistencies 
in the abundance of bacteria present. When observing beta diversity, we found that the 
communities of bacteria present were remarkably changed by the highest concentration of 
fluoxetine for both males and females. Several bacterial families were found to be significantly 
altered in their presence at this high concentration, for instance, Akkermansiaceae and 
Peptostreptococcaceae are found to be significantly less abundant in the highest exposure group 
compared to controls in both sexes. In females, proportions of microbiota influenced by 
fluoxetine were greater than in males. 
Using a network analysis to identify how fluoxetine is impacting clusters of correlated class 
level taxa, fluoxetine was found to majorly influence and be associated with dominant classes in 
the gut microbiome of both sexes. This was a major finding for many of these dominant classes 
hold influential roles on other less predominant clusters of families. Their influence could 
potentiate a cascade effect where, eventually, fluoxetine may subsequently impact other bacterial 
classes.   
As previously hypothesized, fluoxetine may be able to impede growth and thus impact 
colonization of certain bacteria through its ability to bind to sodium symporters homologous to 
that of SERT found on some bacterial cells (Lyte et al., 2019; Lyte and Brown, 2018). Previous 
studies found that certain bacteria respond to serotonin fluxes of its host, suggesting that they 
may hold similar transporters to that of SERT (Fung et al., 2019; Wang et al., 2021). These taxa 
are included in the families Clostridiaceae and Akkermansiaceae which were also identified to 
be diminished in this study. Interestingly, several families in the phyla Proteobacteria that are 
associated with inflammation, pathogenesis, and anxiety (Colwell and Grimes, 1984; De Palma 
et al., 2017; Reid et al., 2008; Song et al., 2016) were found to be more abundant in the highest 
exposure group; while, Akkermansiaceae, a bacterial family found to be almost completely 
eradicated in the highest exposure group for both sexes, is critical for fatty acid oxidation and a 
decrease is correlated with inflammatory markers, disease, and metabolic alterations 
(Schneeberger et al., 2015; Sivixay et al., 2021).  
Although the dysbiosis of the gut microbiome related to fluoxetine exposure was only found 




be used as a proof-of-concept study where we can take away the fact that fluoxetine can indeed 
impact the gut microbiome. Importantly, this work can be used as a read-across hypothesis, 
where we can extrapolate these findings to other vertebrate studies predicting outcomes on 
evolutionarily conserved molecular and bacterial targets (Margiotta-Casaluci et al., 2014). Also, 
continuous release of SSRIs, and the reality of pharmaceutical mixtures within the environment, 
could allow for an increase in the availability and uptake these compounds, causing higher levels 
of SSRIs in the body (Backhaus, 2014; Daughton, 2002; Ding et al., 2017; Paterson and 
Metcalfe, 2008; Schultz et al., 2011; Simmons et al., 2017).  
4.2.3. Linking MIC and metabarcoding results 
Antimicrobial effects were found in both the minimum inhibitory concentration assays 
and the microbiome analysis conducted. However, the results of both studies hold some 
incongruencies. For example, at a genus level, Aeromonas and Plesiomonas were found to 
increase in abundance with increasing concentrations of fluoxetine in the metabarcoding study 
(Appendix K) while the species, Aeromonas veronii, Aeromonas ichthiosmia, and Plesiomonas 
shigelliodes were found to be inhibited by fluoxetine in the MIC tests. These results, however, 
are not entirely comparable as the concentrations used held a difference of approximately a 
thousand-fold. Lyte et al., (2019) also found similar inconsistencies when comparing in vitro 
antimicrobial studies to a 16S metabarcoding analysis where Escherichia was found to be 
inhibited at extremely high concentrations in vitro yet not at the human therapeutic dose when 
mice were exposed. MIC testing is used to understand bacteriostatic effects, where a compound 
can prevent visual growth of bacteria, requiring a high concentration of the compound of interest. 
It is possible that these bacteria may be influenced differently at a substantially higher 
concentration where a biphasic or hormesis effect may occur. 
Strain specific effects could also be happening that cannot be deciphered at the genus level. 
Although the genera Aeromonas and Plesiomonas are higher in abundance at increasing 
concentrations of fluoxetine in the metabarcoding study, using metataxonomic techniques, we 
cannot verify what species we are observing. Intriguingly, in a previous study, two different 
species of the genus Lactobacillus were found to differentially express biogenic amine 
transporters (Lyte and Brown, 2018). Thus, although a greater abundance of genus level 




unfolding at a species level which could be why we see inhibition of growth of certain species in 
these genera in the MIC assays. The two studies conclude that fluoxetine can impede growth of 
certain bacteria found in the gut of fathead minnows, however, continued research needs to be 
conducted exploring the mechanism behind this impediment. 
4.3.Limitations of research and recommendations for future work 
4.3.1. Development limitations to identify transporters on bacterial cells 
Although our hypothesis that growth inhibition of bacterial cells when exposed to 
fluoxetine is caused by transporter inhibition, we were not able to verify the true source of this 
impairment. Lyte and Brown (2018), were able to identify monoamine transporters on a 
Lactobacillus strain using fluorescence-based assays with transporter-specific fluorophores. One 
of the objectives after running the MIC testing of fluoxetine was to use similar methods to see if 
the bacterial cells from this study held these transporters as well. Unfortunately, to run this assay, 
the bacteria must be able to make biofilms or at least adhere to the bottom of a well plate. Due to 
trouble maintaining adhesion of bacterial cells to 24 and 96 well plates, this assay was not able to 
be performed. Future work should be conducted to identify these transporters, potentially using 
agarose gel allowing for adhesion and growth of bacterial cells before running the fluorescence-
based assay. Running gene-specific amplification using quantitative PCR (qPCR) techniques 
with primers designed for the monoamine transporters of interest could be another valuable 
option. However, to run this analysis, genes encoding for transporters of interest must be 
identified (Lyte et al., 2019; Peirson and Butler, 2007). Another possibility would be to use 
transcriptomic or proteomic techniques which can determine gene and protein expression from 
bacterial species (Kolker et al., 2006; Mishra et al., 2019). 
4.3.2. The pros and cons of 16S rRNA metabarcoding 
Advances in high-throughput sequencing has allowed for an upsurge of studies regarding 
the microbiome across scientific fields (Ranjan et al., 2015). There are currently two 
predominant ways to analyze microbiome data, the first being 16S rRNA amplicon sequencing 
which relies on a marker gene, the16S rRNA gene, present in almost all bacteria (Janda and 
Abbott, 2007; Kuczynski et al., 2011). The second method is whole genome shotgun sequencing 




advantageous and limitations. The 16S rRNA technique, used for this study, is currently the most 
common taxonomic identification tool (Brumfield et al., 2020). Amplicon sequencing continues 
to be the more inexpensive technique (Brumfield et al., 2020; Van Nimwegen et al., 2016) and 
may be the better option when running studies with limited sequencing reads (Durazzi et al., 
2021). Using universal primers, we can amplify certain hypervariable regions of the 16S rRNA 
gene and through bioinformatic processing, we can align the obtained sequences against 
sequence databases (Brumfield et al., 2020; Kuczynski et al., 2011) including SILVA Ribosomal 
RNA and Gene Database Project (Quast et al., 2013) or Greengenes (DeSantis et al., 2006). 
Although this tool may be the more cost effective and the practical choice, whole genome 
sequencing tends to be a more accurate and predictable method. 
Whole genome shotgun sequencing uses all DNA which is then fragmented, sequenced 
and aligned independently (Brumfield et al., 2020). Shotgun sequencing, although more 
expensive, tends to be the more advantageous sequencing technique, as long as a sufficient 
amount of reads are obtained (Durazzi et al., 2021). Comparison studies have found that shotgun 
sequencing yields more accuracy in taxonomic classification at lower levels including genus and 
species detection, can better identify diversity of taxa found, and can predict protein features, 
genes and functions of the microbial communities (Brumfield et al., 2020; Durazzi et al., 2021; 
Kuczynski et al., 2011; Ranjan et al., 2015). Additionally, unlike 16S sequencing, shotgun 
techniques can also identify viruses, protozoa and fungi (Ranjan et al., 2015). Although 
metagenomic sequencing data can be assessed to predict function of microbiota, due to 
individual variation of these microbes where highly related bacteria can hold significantly 
different functions, it is not adequate to rely on tools that use community composition to predict 
function (Duperron et al., 2020). Instead, a multi-omic approach may be better suited where we 
can identify gene and protein expression as well as metabolites microbiota produce to better 
explain the functional capabilities they may hold.  
4.3.3. Future work incorporating omics techniques for functional analyses 
To assess functional profiles of the gut microbial communities, future work should be 
conducted using other omic techniques including metatranscriptomics, metabolomics, 
metaproteomics. A multi-omics approach is challenging, yet the ability to use these techniques 




is exposed to a toxicant (Duperron et al., 2020). A multi-omic approach allows us to not only 
observe the abundance of genes, but we can also evaluate gene expression, expression of 
proteins, and metabolite production (Malmuthuge and Guan, 2016). For instance, 
metatranscriptomics, an RNA-based method, identifies microbiota activity through transcription 
and expression of genes (Malmuthuge and Guan, 2016; Whon et al., 2021). Metagenomics may 
be able to identify abundance of genes, however, several of these genes may not be actively 
expressed, which is where metatranscriptomics comes into play (Franzosa et al., 2014; 
Malmuthuge and Guan, 2016).  
Through the use of metaproteomics, studying the expression of proteins produced by the 
microbiome, helps assess the direct activity of these microbes in the gut (Whon et al., 2021). 
Proteins identified using metaproteomic techniques hold highly influential roles within their host, 
for example, inflammatory response proteins and mucosal integrity proteins expressed by 
microbes can influence chronic inflammation in the host organism (Erickson et al., 2012; Lai et 
al., 2019). Use of shotgun metaproteomics has also identified several proteins expressed by 
microbes correlated with energy production, immune responses, and carbohydrate metabolism 
(Lai et al., 2019; Verberkmoes et al., 2009).   
Metabolomics is the study of metabolites; molecules transformed during metabolism 
processes (Whon et al., 2021). Most metabolomic studies are currently conducted using nuclear 
magnetic resonance (NMR) spectroscopy and LC-MS techniques. Using metabolomic methods 
in gut microbiome studies hold some trepidations; to date it is difficult to differentiate which 
microorganism a metabolite came from due to the complex mixture of the gut contents of the 
host and bacterial secretions (Whon et al., 2021; Yan et al., 2016). Identification of metabolites 
can also be tricky due to how quickly they can degrade during the process of extraction (Yan et 
al., 2016). However, because metabolites are, in essence, what is left behind after a cellular 
response, metabolomic methods hold value in microbiome studies, for it can give a better insight 
into the metabolic processes that may be influenced by toxicants (Peters et al., 2019). 
4.4.Concluding statements 
Pharmaceuticals, such as SSRIs, are increasingly and continuously being released into 
aquatic environments. With that, there have been a plethora of environmental toxicology studies 




development, and reproduction. Although it is known that the gut holds the majority of serotonin 
synthesis and several bacterial species hold homologous transporters to that of the serotonin 
reuptake transporter that SSRIs bind to, no ecotoxicological study has previously been conducted 
to determine how the fish gut microbiome is influenced when the host is exposed to an SSRI. In 
fact, the incorporation of the gut microbiome has only recently been recognized in the field of 
ecotoxicology. The gut microbiome is a critical element within host organisms and can interact 
with the immune system, nervous systems, GI function, and brain. Because of our awareness of 
the interconnectedness of the gut microbiome and homeostasis of its host, it is vital to better 
understand how toxicants may impair the gut microbiota and how such perturbations can then 
influence the host organism. This study demonstrated that the xenobiotic, fluoxetine, can impede 
bacteria cell growth in vitro and cause dysbiosis of the gut microbiome. However, it is important 
to note, that the concentration of fluoxetine at which the gut microbiome was affected is far 
greater than anything seen in the environment. This stated, due to continuous release of 
fluoxetine into the environment and its ability to bioconcentrate, a long-term exposure may give 
us a better understanding of how this SSRI may affect the gut microbiome of aquatic organisms. 
Lastly, this work can be applied as a cross-species extrapolation study, for all vertebrates hold 
serotonin systems and microbiomes allowing us to extrapolate from such evidence found here 
and apply it to other organisms. This work gives us a first look regarding how fluoxetine, a 














































Appendix A| Detailed parameters for LCMS quantification of fluoxetine for both chapter 2 and 
3:  
Samples were ionized by positive mode heated electrospray ionization (HESI) with the 
following source parameters: sheath gas flow = 20; aux gas flow = 5; sweep gas flow = 1; aux 
gas heater = 300oC; spray voltage = 3.5 kV; S-lens RF = 60; and capillary temperature = 350oC. 
A targeted-SIM and PRM (collision energy = 20) method at 60,000 resolution, AGC target = 
1x106, and max injection time = 100ms was used to monitor [M+H]+ precursor and product ions 
of fluoxetine (m/z 310.141 → 148.112) and fluoxetine-d5 (m/z 315.173 → 153.143). Precursor 
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Appendix B| Boxplots comparing condition factor against exposure concentrations (A) female 
fish (ANOVA test, p>0.05; n=45); (B) male fish (ANOVA test, p<0.05; n=32). No significant 
differences were identified between concentration of fluoxetine and condition factor of male and 





























Appendix D| NMDS plot based on bootstrap averaged beta-diversities to show the variance of 
















































Appendix E| NMDS plot based on bootstrap averaged beta-diversity. Males in the greatest 















































Appendix F| Table showing reads per sample before and after filtering, denoising, merging and 
removing of chimeras. (Chapter 3) 













10R1 23771 20814 87.56 20530 19716 82.94 18758 78.91 
10R2 108046 94679 87.63 93925 92106 85.25 83333 77.13 
10R3 27899 24375 87.37 24045 23342 83.67 22411 80.33 
10R5 76565 66718 87.14 66104 64527 84.28 59375 77.55 
11R1 54800 48121 87.81 47650 46386 84.65 44548 81.29 
11R2 84409 74539 88.31 74044 72392 85.76 66451 78.73 
11R3 64056 56303 87.9 55652 53740 83.9 47062 73.47 
11R4 85331 73265 85.86 72779 72093 84.49 71669 83.99 
11R5 82650 72023 87.14 71624 70494 85.29 68829 83.28 
12R1 91713 79911 87.13 79587 79090 86.24 78461 85.55 
12R2 72499 64053 88.35 63379 61684 85.08 54701 75.45 
12R3 60670 53625 88.39 53380 53040 87.42 52710 86.88 
12R4 49037 43129 87.95 42618 41007 83.62 37176 75.81 
12R5 5100 4435 86.96 4332 4267 83.67 4239 83.12 
13R1 78187 68495 87.6 68211 67781 86.69 67272 86.04 
13R3 196660 174047 88.5 173145 169770 86.33 123743 62.92 
13R4 31527 26856 85.18 26654 26339 83.54 26253 83.27 
13R5 89009 79274 89.06 79021 77855 87.47 65108 73.15 
14R1 97706 85531 87.54 85006 83548 85.51 78720 80.57 
14R2 78301 69450 88.7 68930 67006 85.57 59677 76.21 
14R3 1059 760 71.77 721 703 66.38 703 66.38 
14R4 70557 62375 88.4 61831 60343 85.52 55397 78.51 
14R5 116 105 90.52 73 57 49.14 47 40.52 
15R2 50619 44255 87.43 43754 42689 84.33 41745 82.47 
15R4 191025 167242 87.55 166531 163825 85.76 150610 78.84 
16R1 42038 36686 87.27 36289 35355 84.1 33201 78.98 
16R2 119429 105377 88.23 104800 102440 85.77 87388 73.17 
16R3 61802 54324 87.9 53863 52783 85.41 50630 81.92 
16R4 75500 65916 87.31 65438 63839 84.55 58246 77.15 
16R5 94265 83666 88.76 83375 82609 87.63 79180 84 
17R1 50453 42407 84.05 42223 41862 82.97 41651 82.55 
17R2 60410 52725 87.28 52400 51688 85.56 51332 84.97 
17R3 75858 65995 87 65370 63221 83.34 57451 75.73 
17R5 76433 67061 87.74 66541 65126 85.21 61027 79.84 
18R1 73400 62661 85.37 62322 61756 84.14 60783 82.81 




18R3 79479 68590 86.3 68362 67860 85.38 67281 84.65 
19R2 74150 64770 87.35 64690 64512 87 60076 81.02 
19R3 30764 27044 87.91 26642 25675 83.46 23977 77.94 
19R4 36195 31825 87.93 31657 31453 86.9 31329 86.56 
19R5 18164 15945 87.78 15817 15675 86.3 15621 86 
1R2 18627 16427 88.19 15957 14788 79.39 11949 64.15 
1R3 50154 44317 88.36 43691 41737 83.22 31741 63.29 
1R4 73271 64818 88.46 64186 62061 84.7 54731 74.7 
1R5 97595 86349 88.48 85644 83424 85.48 74640 76.48 
20R1 87092 76155 87.44 75701 74195 85.19 68872 79.08 
20R2 72803 63040 86.59 62462 60579 83.21 56229 77.23 
20R3 15207 13283 87.35 13135 12914 84.92 12696 83.49 
20R5 107156 94950 88.61 94247 92192 86.04 73735 68.81 
2R2 63308 55316 87.38 54856 53556 84.6 50439 79.67 
2R3 64461 56831 88.16 56105 53918 83.64 45813 71.07 
2R4 81520 71685 87.94 71106 69473 85.22 63744 78.19 
2R5 46761 40719 87.08 40579 40338 86.26 40235 86.04 
3R3 57417 49084 85.49 48791 48296 84.11 48112 83.79 
3R4 72308 63499 87.82 62970 61311 84.79 56380 77.97 
3R5 76008 67313 88.56 66614 64235 84.51 55284 72.73 
4R1 68788 59910 87.09 59535 58634 85.24 56760 82.51 
4R3 54228 47743 88.04 47371 46059 84.94 39619 73.06 
4R4 23046 20298 88.08 20009 19577 84.95 19151 83.1 
4R5 29312 25802 88.03 25516 24817 84.66 23876 81.45 
5R2 44198 38988 88.21 38628 37632 85.14 34817 78.78 
5R3 117491 103372 87.98 102665 100337 85.4 89798 76.43 
5R5 62594 54411 86.93 53958 52480 83.84 48906 78.13 
6R2 51814 45631 88.07 45386 44834 86.53 44062 85.04 
6R3 59402 51610 86.88 51168 50209 84.52 48775 82.11 
6R4 26873 23655 88.03 23449 23060 85.81 22574 84 
6R5 111762 98300 87.95 97853 96427 86.28 93335 83.51 
7R1 56125 49083 87.45 48891 48611 86.61 48393 86.22 
7R2 73769 64416 87.32 64002 63207 85.68 61451 83.3 
7R3 35098 30972 88.24 30635 29862 85.08 26283 74.88 
7R4 31429 27712 88.17 27377 26416 84.05 24681 78.53 
8R1 77411 67395 87.06 66838 64964 83.92 59648 77.05 
9R1 50976 44191 86.69 43874 43174 84.69 41996 82.38 
9R2 30780 26409 85.8 26146 25606 83.19 24897 80.89 
9R3 74355 65801 88.5 65612 65039 87.47 59640 80.21 
9R4 33822 29696 87.8 29461 29157 86.21 28824 85.22 































Appendix G| (A) Top 10 most abundant families in female fish that were significantly reduced in the high 
exposure group compared to controls. (B) Relative abundance of family level taxa that were significantly 



































Appendix H| Relative abundance of family level taxa that are significantly reduced in the high exposure 
group compared to the control in males (A). Relative abundance of family level taxa that is significantly 

























Appendix J| Genera level heatmaps, of females (A) and males (B), representing the correlation between abundance of 
genera level taxa and fluoxetine concentrations. Greyscale indicates proportion of taxa, the darker the more abundant. 
Concentrations of fluoxetine include ctrl, low, mid and high. Pearson’s correlation coefficient depicted in the blue-red 
scale, positive correlation (higher fluoxetine concentration and higher abundance of taxa) is shown in red while a negative 
correlation (high fluoxetine and lower abundance of ASVs) is shown in blue. (Chapter 3) 
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Appendix K| Heatmap of ASVs, Females (A), Males (B), representing the correlation between abundance of 
ASVs and fluoxetine concentrations. Greyscale indicates proportion of taxa, the darker the more abundant. 
Concentrations of fluoxetine include ctrl, low, mid and high. Pearson’s correlation coefficient depicted in the blue-
red scale, positive correlation (higher fluoxetine concentration and higher abundance of ASVs) is shown in red 












Appendix L| Summary of statistics from the Neighborhood Selection Network analyzer for male 
and female fish. 
  
Network analysis                
Summary of Statistics  
       
Females     Males 
Number of nodes 209 171 
Number of edges 562 339 
Avg. number of 
neighbors 
5,378 4,238 
Network diameter 8 11 
Network radius 5 6 
Characteristic path length 3.52 3.949 
Clustering coefficient 0.16 0.206 
Network density 0.026 0.027 
Network heterogeneity 0.673 0.792 
Network centralization 0.187 0.221 
Connected components 1 12 















Appendix M| ASSESSING WHITE BLOOD CELL COUNTS AS AN INDICATOR FOR 




















The gut microbiome can influence the immune system of its host (Aidy et al., 2014; 
Chung et al., 2012; Dinan and Cryan, 2017; and Montalban-Arques et al., 2015). Gut microbiota 
are critical during the development and maturation of immune cells including stimulation of an 
immune response through antigen production (Chung et al., 2012) and molecular communication 
via cytokines and hormones (Aidy et al., 2014). Several immune cells can even produce 
neurotransmitters which can also influence gut bacteria, and the CNS, potentiating mood and 
behavioral responses (Aidy et al., 2014). Immune cells, including B, T, eosinophils, and 
basophils, express several types of serotonin transporters and any changes of these receptors can 
greatly influence the immune system (Coates et al., 2017). With evidence that the immune 
system produces and responds to neurotransmitters such as serotonin and the importance of the 
microbiome on immune responses, it is valuable to assess how fluoxetine may modulate the 
immune system and how immune system responses to fluoxetine may influence the gut 
microbiome, or vise-versa (fluoxetine modulation of the gut microbiome may influence the 
immune system). 
Considering the importance of neurotransmitters in immune system responses, few 
studies have been conducted within the field of ecotoxicology to identify how SSRIs may affect 
immune function. However, there has been some speculation, including, how an increase of 
circulating serotonin due to fluoxetine exposure may cause beneficial changes to the immune 
system or potentiate autoimmune diseases (Brooks et al., 2003a). The few ecotoxicology studies 
concerning immune responses to fluoxetine found fluoxetine can change Ca2+ homeostasis, 
hamper cell viability, disrupt neurotransmitter signal transduction, and cause a hormesis effect on 
hemocyte counts in bivalves (Munari et al., 2014; Shi et al., 2019). Studies have been conducted 
looking at mammalian immune responses to fluoxetine. A review of these findings by Frick and 
Rapanelli (2013) identified SSRIs to increase natural killer cell activity, suppress bacterial 
antigen presentation of dendritic cells to T cells, modulate cytokine production, and reduce 
production of tumor necrosis factor-α. Fluoxetine was also found to increase T cell proliferation 
at low concentrations while causing an inhibitory effect at high doses, potentially through 
nonspecific toxicity (Frick and Rapanelli, 2013). With few studies conducted in the realm of 




how the immune function of fathead minnows may be affected by fluoxetine. The objective of 
this study was to run a white blood cell (WBC) count to identify any abnormalities in the number 
types of cells observed after fish were exposed to three different concentrations of fluoxetine. 
The null hypothesis for this study was that there would be no differences in the type of white 
blood cells identified or counted after fish were exposed to any concentration of fluoxetine. 
2. Material and methods  
2.1. General Methods 
After a 28-day fluoxetine exposure to fathead minnows with aqueous concentrations of 
0.01, 10 and 100 µg/L, fish were euthanized, and blood was taken from the caudal vein to 
assess the immune system response to fluoxetine via white blood cell quantification. For in-
depth methods regarding the fish exposure and fluoxetine quantification parameters see 
chapter 3.  
2.2. Blood smears 
After anesthetization with MS-222, the caudal fin was cut and a capillary tube was placed at 
the base of the caudal vein to allow for blood to enter the tube. A drop of blood was placed on a 
glass microscope slide. Using a second slide at a 45-degree angle, blood was smeared across the 
slide. The slide was let to dry and then dipped in methanol to fix the blood and placed in a slide 
box until further analysis. Before cell counting, slides were stained using the Hema 3™ Manual 
Staining System and Stat Pack following manufacturers guidelines (Fisher Scientific, Middleton, 
VA).  
2.3. White blood cell counting  
White blood cell counting took place using an Olympus BX41 compound microscope. Total 
leukocyte counts were done at 40x in the monolayer. Leukocytes were counted within ten fields 
per slide and the average was then determined. A Fudge Factor of 2,000 for the 40x objective 
was multiplied to the average white blood cell count to estimate the number of cells per µL. A 
100-cell leukocyte differential was performed under oil immersion 100x lens within the 
monolayer. Running the slide in a zig-zag pattern all leukocytes were differentiated until 100 
cells were counted. Methods were performed based on Rodak’s Hematology: Clinical Principles 
and Applications (Rodak, 2016). Leukocytes were categorized by their shape and affinity to the 




the total leukocyte count and the leukocyte differentials were conducted twice for better 
accuracy.  
3. Statistics  
Differences between total white blood cell counts and fluoxetine exposure concentrations 
were determined using an analysis of variance (ANOVA) with a Tukey HSD test (if the ANOVA 
held a p<0.05) to determine significance. By observing a Residual vs. Fitted plot and a quantile-
quantile plot, as well as a Levene’s test and Shapiro-wilk test, homogeneity of variance and 
normal distribution were determined before continuing on with the analysis. If these two 
assumptions were not met, tests were re-run on the logged transformed dataset. Because sex is 
known to have an effect on the immune system (Modrá et al., 1998; Rizzetto et al., 2018), a 
Welch’s t-test was performed to identify if sex plays a role in total white blood cell counts. 
Again, if normal distribution and homogeneity of variance were not met, tests were conducted on 
the log-transformed data. All statistical analyses were run in R Statistical Language v 4.0.3 (R 
Core Team, 2020). 
4. Results  
Sex of fish did not play a role in total white blood cell count. Using the log-
transformation of the data, a Welch’s t-test revealed no significant difference between males and 
females when it came to total white blood cell counts (Figure 1, B).  
A significant difference was found when comparing total white blood cell counts to 
fluoxetine exposure groups. The group exposed to the middle concentration (10 µg/L, nominal 
concentration) was found to have a significantly higher WBC count on average compared to fish 
in the control group (p=0.03). Although not statistically significant, the middle exposure group 
had a notably higher white blood cell count compared to the low group (p=0.057). No difference 






A potential hormesis or biphasic response was identified when comparing total white blood 
cell counts to fluoxetine exposure; the middle exposure group was found to have a higher 










Appendix M.1| Assessment of log-transformed average white blood cell counts with fluoxetine 
exposure groups. The middle exposure group was found to have a higher white blood cell count 
than controls (A). Log transformed white blood cell counts in relation to sex of fish (B). 
Separation of sexes within each exposure group compared to log-transformed average white 




difference in number of WBCs comparing the middle and low exposure groups. No differences 
were found when comparing the high and middle groups. The results of this study, although 
predictive, are difficult to make any solid conclusions from. White blood cell counts can give an 
overall estimate of an immune system response and can help identify if there is an infection, 
inflammation or other non-specific immune responses within the body (George-Gay and Parker, 
2003), however, it is much more insightful to run white blood cell differentials, where each type 
of WBC is counted (Blumenreich, 1990; Fazio, 2019; Wester et al., 1994). For example, an 
increase in neutrophils is linked to bacterial and fungal infections and inflammatory diseases 
(Campbell, 2015; Ghosh et al., 2016). Furthermore, identifying the ratio between lymphocytes 
and neutrophils is found to be a critical observation where toxic substances have been shown to 
decrease this ratio in fish species as reviewed by Modra et al., (1998). Unfortunately, due to 
difficulties in differentiating several types of immune cells in the blood of our study species and 
the lack of data on several fish species including fathead minnow immune cell averages and 
appearance (Fazio, 2019; Palić et al., 2005; Thomas et al., 1999), confidence was lacking in the 
data collected from the blood cell differentials, thus it was not used in the analysis.  
Even with differential white blood cell counts there are still biases, importantly, counting 
error, when it comes to manual cell counting (Fazio, 2019; Garrey and Bryan, 1935). Other, 
more accurate, tools have been developed to better address immunotoxic responses. As reviewed 
by Rehberger et al., 2017, there are several different ways to predict immune system responses to 
toxicants including genomic assessments, where the identification of immune-related genes is 
conducted, namely cytokines, including interleukins and tumor necrosis factor. A few studies 
have even used transcriptomic approaches to assess immune system function and pathways 
(Shelley et al., 2012; Thornton Hampton et al., 2020). Other assessments used to address 
immune responses to toxicants include phagocytic activity identification using fluorescent-
labeled beads and flow cytometry (Müller et al., 2009) and the use of nitro blue tetrazolium to 
identify respiratory bursts intended to kill pathogens (Kollner et al., 2002; Rehberger et al., 
2017).  
There is currently little information regarding the effects of fluoxetine on aquatic organisms’ 
immune systems, however, there is an important need to investigate this further due to our 




immunotoxicology is not without its challenges it is important to differentiate direct and indirect 
effects of toxicants on the immune system. Furthermore, the resting immune system may not 
show any significant perturbations but may indeed be impacted during a pathogen challenge 
(Rehberger et al., 2017; Thornton Hampton et al., 2020). Because of the complexity of the 
immune system, there is not just one test that is the most adequate to understand immunotoxicity, 
instead multiple tests may be conducted to estimate effects of the immune system (Rehberger et 
al., 2017). The study conducted here was merely a first insight into the implications fluoxetine 
may have on the immune system, but it is in no way conclusive and must be expounded upon 
using assays previously discussed to better identify if SSRIs hold modulatory abilities on the 
immune system.  
Assessments of the immune system in combination with the gut microbiome in 
ecotoxicological studies can give us a better perspective on how the two may be interacting, for 
they both are critical in intestinal health and inflammatory responses (Yoo et al., 2020). Future 
work should be considered using a blended approach to better assess the impact of xenobiotics, 
such as SSRIs, on the microbiome in combination and relation to the immune system. This will 
give further insight into whether both systems may be perturbed and if there are direct or indirect 
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